Table Of Content

POSTGRADUATE MEDICINE: JANUARY-JUNE 2000 N DE X T 0 VOLUME Subjects ABDOMEN AIRWAY OBSTRUCTION * Dyslipidemia in patients with type 2 diabetes ¢ Pain in irritable bowel syndrome, diagnostic e Asthma, “steroid burst” therapy, current rec- evidence-based therapy. 107(5):31 criteria, treatment options. 107(3):203* ommendations. (CC) 107(1):227 ¢ Endocarditis, bacterial, risk factors, clinical ACNE ¢ Obstructive sleep apnea, evaluation. 107(3):110 presentation, and treatment. 107(1):75* ¢ Topical therapy, guidelines for setting up ALCOHOL ¢ Hypertension in patients with diabetes, need treatment plans. 107(3):69* ¢ Effect on acetaminophen metabolism. 107(1) for aggressive treatment. 107(2):53* ACQUIRED IMMUNODEFICIENCY SYNDROME: 189 ¢ Hypertension in patients with diabetes, over- See AIDS ALLERGY coming barriers to effective control. 107(3):29* ADOLESCENT MEDICINE: See Pediatrics ¢ Cosmetic product allergies, problem-oriented ¢ Hypertension in patients with diabetes, phar- AGING approach to sensitive skin. 107(7):70* macologic interventions to reduce complica- ¢ Bullous pemphigoid, diagnosis and treatment ¢ Toxic epidermal necrolysis, hypersensitivity tions. 107(4):47* (PP) 107(2):231 reaction to trimethoprim-sulfamethoxazole e Hypertension in patients with type 2 diabetes ¢ Common urologic problems, diagnosis and (PD) 107(4):29 evidence-based therapy. 107(5):27 management, ways to prevent serious compli- ANTIBIOTICS: See Drugs, antibiotic ¢ Hypertension, resistant, careful evaluation to cations. 107(1):163* ASTHMA determine contributing factors. 107(5):57* ¢ Evaluation of nursing home patients, system- * Exercise-induced, in-office diagnosis. (CC) ¢ Hypertrophic cardiomyopathy, tools for identi- atic approach. 107(2):201* 107(2):48 fying risk and alleviating symptoms. 107(7):127* ¢ Fitness to drive, assessing the elderly or pa- ¢ “Steroid burst” therapy, current recommen- ¢ Lipid disorders, treatment strategies in pa- tients with dementia. 107(3):229* dations. (CC) 107(1):227 tients with and without known coronary artery ¢ Infectious mononucleosis in older adults disease. (GL) 107(5):139* 107(7):179 BEHAVIOR DISORDERS ¢ Lipid screening in preventing coronary artery ¢ Laboratory data in the elderly. 107(7):156 ¢ In elderly patients, avoiding and minimizing disease. (GL) 107(4):229* ¢ Long-term care, physician’s role in directing side effects of antipsychotic drugs. 107(2):169* ¢ Non-Q wave myocardial infarction, assess- care. 107(2):217* BIOPSY ment and management. 107(2):87* ¢ Physical restraint in nursing home, reducing ¢ Aspiration, of thyroid nodule. 107(1):115 ¢ Pleural effusions, correlating evidence with use. (ED) 107(2):15 ¢ Liver, assessment of abnormal liver enzyme the cause. 107(4):95* ¢ Side effects of antipsychotic drugs, avoiding levels. 107(2):109 ¢ Risk from periodontal infection. (CC) 107(5):17 and minimizing their impact in the elderly BITES AND STINGS ¢ Stroke, acute ischemic, role of tPA and anti- 107(2):169* ¢ Jellyfish stings, treatment. (CC) 107(4):27 thrombotic agents in management. 107(6):85* AIDS BLOOD GLUCOSE ¢ Stroke, ischemic, current approaches to pri- e Ethical and financial imperatives in HIV care. ¢ Hyperglycemia in patients with type 2 dia- mary and secondary prevention. 107(6):34* (ED) 107(4):15 betes, two recent prospective trials. 107(5):33 ¢ Stroke, patient information. (PN) 107(6):157 ¢ HIV disease in children, how it differs from BREAST DISEASES CATHETERIZATION disease in adults. 107(4):163* ¢ Hereditary breast cancer syndromes, use of ¢ Indwelling, management to reduce risk of ¢ Updated patient information. (PN) 107(4):263 genetic screening. 107(4):193 long-term problems. 107(1):177 CHOLESTEROL CANCER: See Neoplasms ¢ Dyslipidemia in patients with type 2 diabetes CARDIOVASCULAR DISEASES evidence-based therapy. 107(5):31 *Major clinical discussion ¢ Carotid artery stenosis, current recommenda- ¢ Effect of lipid levels on risk of coronary artery CC, Curbside Consults DD, Digital Doc tions on carotid endarterectomy. 107(6):97* disease in women. 107(6):113 ED, Editorial ¢ Cerebral infarction and transient ischemic at- ¢ Lipid disorders, treatment strategies in pa- GL, Clinical Practice Guidelines tacks, diagnostic evaluation essential to benefi- tients with and without known coronary artery PD, Pearls in Dermatology cial intervention. 107(6):55* disease. (GL) 107(5):139* PN, Patient Notes ¢ Coronary artery disease in women, gender- ¢ Lipid screening in prevention of coronary artery PP, Puzzles in Practice specific statistics and prevention strategies. disease. (GL) 107(4):229* 107(6):111* continued VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE 197 INDEX TO VOLUME 107 CONTINUED COLONIC DISEASES: See Gastrointestinal dis- ¢ For identification of genetic liver disease in DRUGS, ANTIFUNGAL eases adults. 107(2):147 ¢ Interaction with other drug therapy when treat- COMPUTERS ¢ Goals of diagnostic evaluation in patients with ing superficial fungal infections. (PD) 107(1):41 * CD-ROM decision-support tools, where to find cerebral infarction or transient ischemic attacks. DRUGS, ANTIHYPERTENSIVE Clinical practice guidelines and best-practice in- 107(6):55* ¢ For resistant hypertension, need for carefully formation. (DD) 107(1):27 ¢ In-office diagnosis of exercise-induced asth- conducted evaluation. 107(5):57 « E-mail in your medical practice. (DD) 107(7):31 ma. (CC) 107(2):48 DRUGS, ANTIPLATELET ¢ Equipping a waiting room kiosk with patient ¢ Laboratory and imaging studies in diagnosis e In prevention of ischemic stroke. 107(6):42, 48 information. (DD) 107(4):41 of bacterial endocarditis. 107(1):81 DRUGS, ANTIPSYCHOTIC ¢ Increased bandwidth improves speed and ex- ¢ Serologic and molecular testing for accurate ¢ Avoiding and minimizing side effects in elder- pands options. (DD) 107(2):35 identification of viral causes of acute and chron- ly patients. 107(2):169* e Virus protection software. (DD) 107(5):21 ic hepatitis. 107(2):123* DRUGS, ANTIVIRAL CORTICOSTEROIDS: See Drugs, corticosteroid DIET: See Nutrition ¢ Antiretroviral therapy during primary HIV in- DRUG THERAPY fection. 107(4):129 DELIVERY OF HEALTHCARE ¢ Antihypertensive therapy for resistant hyper- « Antiretroviral therapy for treatment of HIV in- ¢ Secrets of successful medical practice. (ED) tension, need for carefully conducted evalua- fection and AIDS, associated metabolic and 107(7):23 tion. 107(5):57* morphologic abnormalities. 107(4):141* e US healthcare, is it time for a national sys- For bacterial endocarditis. 107(1):82 ¢ Antiretroviral treatment of HIV disease in chil- tem? (ED) 107(5):13 e For both hypertension and hyperglycemia dren. 107(4):171 DEMENTIA 107(2):61 ¢ For acute herpes zoster. 107(7):114 ¢ Effect on fitness to drive, physician’s role in ¢ For diabetic hypertensive patients, pharmaco- ¢ For chronic hepatitis B and C, indications for assessment. 107(3):229* logic interventions to reduce complications. and contraindications to antiviral therapy. DENTAL DISEASES 107(4):47* 107(2):135* ¢ Oral, dental, and facial pain, temporary con- ¢ For HIV infection, recommendations for 2000. ¢ For treatment of herpes infections. 107(3):194 trol using dental nerve blocks. 107(1):229* 107(4):127 * Salvage antiretroviral regimens, basic guide- * Periodontal infection a risk factor for cardio- ¢ For osteoporosis, current options. 107(7):47 lines for design and use of resistance testing. vascular disease. (CC) 107(5):17 ¢ For treatment of endometriosis, characteris- 107(4):149* DIABETES tics of commonly used medications. 107(3):216 ¢ Suppressive and intermittent therapy for re- ¢ Combined with hypertension, need for ag- ¢ Postinfarction treatment regimens. 107(2):90 current herpes simplex virus infection. (PD) gressive treatment. 107(2):53* ¢ Salvage antiretroviral regimens in HIV medi- 107(6):140 ¢ Complicated by hypertension, pharmacologic cine. 107(4):149* DRUGS, BETA BLOCKERS interventions. 107(4):47* ¢ Tissue plasminogen activator therapy in man- ¢ For non—-Q wave infarction. 107(2):91 ¢ Dermatologic sign, finger “pebbles.” (PD) agement of acute ischemic stroke. 107(6):86 DRUGS, CALCIUM CHANNEL 107(3):209 DRUGS, ACE iNHIBITOR ¢ For non—Q wave infarction. 107(2):91 e Risk factor for coronary artery disease in ¢ In non-Q wave infarction. 107(2):90 DRUGS, CORTICOSTEROID women. 107(6):113 DRUGS, ADVERSE REACTION ¢ Adjunctive, in management of pulmonary and * Safety of oral hyperglycemic drugs in patients ¢ Case of toxic epidermal necrolysis induced by extrapulmonary tuberculosis. (CC) 107(4):102 with renal disease. (CC) 107(7):66 trimethoprim-sulfamethoxazole. (PD) 107(4):29 ¢ Intralesional and topical, for alopecia areata. * Type 2, comprehensive staged management e Fixed drug eruption, differential diagnosis. 107(7):84 to improve quality of patient care. 107(5):27* (PP) 107(7):191 e “Steroid burst” therapy for asthma, current ¢ With hypertension, overcoming barriers to ef- DRUGS, ANTIANDROGEN recommendations. (CC) 107(1):227 fective control. 107(3):29* ¢ In treatment of hirsutism. 107(7):101 DRUGS, NONPRESCRIPTION DIAGNOSTIC IMAGING DRUGS, ANTIBIOTIC ¢ Acetaminophen, hepatotoxicity in users and ¢ Evaluation of thyroid nodule. 107(1):114 ¢ For community-acquired pneumonia. (GL) nonusers of alcohol. 107(1):189* ¢ In thyroid cancer. 107(1):123 107(2):251 DRUGS, NONSTEROIDAL ANTI-INFLAMMATORY ¢ Thyroid-imaging techniques. 107(1):103 ¢ For treatment of Lyme disease. (PD) 107(5):52 (NSAIDs) DIAGNOSTIC TECHNIQUES * Gonococcal resistance to antimicrobial thera- ¢ For management of cancer pain. 107(3):268 ¢ Approach to hyperbilirubinemia and jaundice. py. 107(2):183 DRUGS, OPIOID 107(2):108 DRUGS, ANTIDIABETIC * For management of cancer pain. 107(3):269 ¢ Densitometry techniques to measure bone ¢ Oral hyperglycemic agents, safety in patients DRUGS, RETINOID mass. 107(7):39 with renal disease. (CC) 107(7):66 ¢ Tretinoin for acne. 107(3):75 ¢ For hypertrophic cardiomyopathy. 107(7):129 198 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED DRUGS, THROMBOLYTIC genetic screening. 107(4):198 traindications to antiviral therapy. 107(2):135* * Catheter-directed thrombolysis for ischemic ¢ Colorectal cancer, importance of education ¢ B vaccine, what to do about healthcare work- stroke. 107(6):90 and screening to improve outcomes. 107(5):96* ers who are “nonresponders.” (CC) 107(3):97 ¢ Colorectal cancer, patient information. (PN) Patient information. (PN) 107(2):279 EAR DISEASES 107(5):185 ¢ Viral, acute and chronic, serologic and molec- ¢ Otitis media in children, diagnosis, treatment ¢ Columnar-lined (Barrett’s) esophagus, defin- ular testing for accurate identification of viral and prevention. (GL) 107(3):239* ing the condition, current strategies in preven- causes. 107(2):123* ELDERLY: See Aging tion and management. 107(7):59* HEREDITARY DISEASES ENDOCRINE DISORDERS ¢ Esophageal cancer, role of primary care physi- ¢ Genetic counseling in primary care, likely ¢ Autoimmune thyroid disease, recognition and cian in diagnosis and treatment. 107(5):109* questions and their answers. 107(3):59* treatment. 107(1):127* ¢ From foodborne and waterborne infectious * Genetic liver disease in adults, early recogni- ¢ Diabetes: See Diabetes diseases, new and reemerging pathogens tion of three most common causes. 107(2):147* ¢ Galactorrhea, three cases demonstrate need 107(4):245* ¢ Genetic screening in patients of reproductive for thorough workup. 107(7):165* ° Hepatocellular carcinoma, guide to detection, age, pros and cons of testing. 107(6):121* ¢ Hirsutism in women, clinical presentation, treatment, and prevention. 107(5):117* * Genetic testing and counseling. (ED) 107(3):15 evaluation, and treatment. 107(7):93* ¢ Irritable bowel syndrome, diagnostic criteria, ¢ When to use genetic screening for hereditary ¢ Hypothyroidism. (PN) 107(1):263 treatment options. 107(3):203* cancers. 107(4):191* ¢ Male factors in infertility, diagnosis and treat- GENETIC COUNSELING HORMONES ment. 107(2):235* ¢ Current status and expanding horizons. (ED) ¢ Replacement therapy, effect on coronary artery ¢ Palpable thyroid abnormality, identification 107(3):15 disease risk. 107(6):114 and treatment. 107(1):100* ¢ In primary care, likely questions and their an- HYPERTENSION: See Cardiovascular diseases ¢ Premenstrual syndrome, diagnostic criteria, swers. 107(3):59* treatment to relieve symptoms. 107(5):151* GENETIC DISORDERS: See Hereditary diseases IMMUNIZATION ¢ Subclinical, diagnostic approach to mild labo- GENITAL DISEASES ¢ For influenza virus. 107(3):45 ratory abnormalities and vague or absent symp- ¢ Herpes simplex virus type 2 infections, diag- ¢ Hepatitis B vaccine, what to do about health- toms. 107(1):143* nosis and treatment. 107(3):193 care workers who are “nonresponders.” (CC) ¢ Thyroid nodules, epidemiology, evaluation, ¢ Infectious vaginitis, diagnosis and treatment. 107(3):97 and treatment. 107(1):113* 107(4):63* ¢ Polio vaccine, changes in administration. (CC) ETHICS, MEDICAL ¢ Male infertility, myths about, education and 107(1):33 ¢ Ethical and financial imperatives in HIV care. treatment, when to refer. 107(2):235* IMMUNOLOGIC DISEASES (ED) 107(4):15 GERIATRICS: See Aging ¢ Alopecia areata, clinical overview. 107(7):81* EXERCISE GUIDELINES, CLINICAL PRACTICE ¢ Autoimmune thyroid disease, recognition and ¢ Cause of asthma, in-office diagnosis. (CC) ¢ Community-acquired pneumonia, guidelines treatment. 107(1):127* , 107(2):48 for outpatient management. (GL) 107(2):246* ¢ HIV and AIDS update. (PN) 107(4):263 EYE DISORDERS ¢ In treatment of lipid disorders, strategies in ¢ HIV disease in children, how it differs from ¢ Excessive tearing in infancy and early child- patients with and without known coronary disease in adults. 107(4):163* hood, role and treatment of congenital naso- artery disease. (GL) 107(5):139* ¢ HIV infection, practical approach to therapy. lacrimal duct obstruction. 107(6):149* ¢ Lipid screening in prevention of coronary 107(4):127* ¢ Ocular involvement in cicatricial pemphigoid, artery disease. (GL) 107(4):229* e HiV-associated metabolic and morphologic diagnosis and treatment. (PP) 107(3):85 * Otitis media in children, diagnosis, treatment, abnormality syndrome, unwelcome effects of and prevention. (GL) 107(3):239* antiretroviral therapy. 107(4):141* FAMILY PRACTICE ¢ Where to find clinical practice guidelines and * Primary HIV infection, current trends in trans- ¢ Growing need for and interest in addressing best-practice information, CD-ROM decision- mission, testing, and treatment. 107(4):114* women’s health issues. (ED) 107(1):15 support tools. (DD) 107(1):27 e Raynaud’s phenomena, risks of pregnancy. FEVER (CC) 107(1):47 ¢ Without source in young children, recom- HEART DISEASE: See Cardiovascular diseases INCONTINENCE mendations for outpatient care. 107(2):259* HEMATOLOGIC DISEASES e Urinary, in elderly women, diagnosis and FUNGAL DISEASES ¢ Sickle cell disease, recognition of acute chest management. 107(1):169 ¢ Antifungal drug interactions. (PD) 107(1):41 syndrome in adolescents and adults, evaluation INFANTS and treatment. 107(1):215* ¢ Excessive tearing, role and treatment of congen- GASTROINTESTINAL DISEASES HEPATITIS ital nasolacrimal duct obstruction. 107(6):149* ¢ Colon cancer, hereditary syndromes, use of e B and C, chronic, indications for and con- continued VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE 199 INDEX TO VOLUME 107 CONTINUED * Febrile, without toxic signs and symptoms, rec- INFERTILITY ¢ Physician’s role in directing care, understand- ommendations for outpatient care. 107(2):259 ¢ Male, myths about, education and treatment, ing the rules to protect your patients and your INFECTION when to refer. 107(2):235* practice. 107(2):217* ¢ Bacterial endocarditis, risk factors, clinical INFLUENZA ¢ Systematic approach to evaluation of nursing presentation, and treatment. 107(1):75* ¢ Clinical manifestations, diagnosis, and treat- home patients. 107(2):201* ¢ Chlamydia trachomatis and herpes simplex ment. 107(3):41 LUNG DISEASES infections in women, diagnosis, treatment, and INSOMNIA ¢ Acute chest syndrome in sickle cell disease, prevention. 107(1):55* ¢ Types, diagnosis and treatment. 107(3):127* evaluation and treatment. 107(1):215* * Community-acquired pneumonia, guidelines INTERFERON ¢ Pleural effusions in cardiovascular disease, for outpatient management. (GL) 107(2):246* ¢ Therapies for chronic hepatitis B and C correlating evidence with the cause. 107(4):95* ¢ Foodborne and waterborne infectious dis- 107(2):135 LYME DISEASE eases, contributing factors and solutions to new ¢ Erythema migrans, cutaneous hallmark of dis- and reemerging pathogens. 107(4):245* KIDNEY DISEASES ease, diagnosis and treatment. (PD) 107(5):51 ¢ Fungal, treatment resulting in drug interac- ¢ In patients with diabetes, safety of oral hyper- tions. (PD) 107(1):41 glycemic drugs. (CC) 107(7):66 MEDICAL PRACTICE ¢ Gonorrhea and syphilis in women, screening, ¢ Secrets to success, details make the differ- diagnosis, and treatment. 107(2):181* LABORATORY INVESTIGATION ence. (ED) 107(7):23 ¢ Herpes simplex virus, characteristics and ¢ Antiretroviral-drug and HIV-resistance testing ¢ Waiting room kiosk with patient education re- promising treatment options. 107(3):189* in HIV medicine. 107(4):149* sources. (DD) 107(4):41 * Herpes simplex virus, recurrent, suppressive ¢ Diagnosis of viral pneumonia. 107(1):68 MEN and reactive antiviral regimens. (PD) 107(6):139 ¢ Evaluation of thyroid function. 107(1):104 ¢ Common urologic problems in elderly men, ¢ HIV and AIDS update. (PN) 107(4):263 ¢ In diagnosis of infectious mononucleosis. diagnosis and treatment. 107(1):163 * HIV-associated metabolic and morphologic 107(7):177 e Myths about male infertility, education and abnormality syndrome. 107(4):141* « In evaluation of acid-base disorders. 107(3):250 treatment, when to refer. 107(2):235* e HIV, designing salvage antiretroviral regi- ¢ Liver function tests, interpreting results to METABOLIC DISEASES mens, basic guidelines and use of resistance narrow diagnosis. 107(2):100* ¢ Acid-base disorders, step-by-step approach testing. 107(4):149* ¢ Microalbuminuria in patients with type 2 dia- to diagnosis and treatment. 107(3):249* ¢ HIV disease in children, how it differs from betes. 107(5):38 METABOLISM disease in adults. 107(4):163* ¢ Problems in interpreting laboratory test re- ¢ Sodium and water, disorders, general approach ¢ HIV, ethical and financial imperatives. (ED) sults. 107(7):145* to evaluation and management. 107(5):75* 107(4):15 ¢ Serologic and molecular testing for identifica- MOUTH DISEASES * HIV, practical approach to therapy. 107(4):127* tion of viral causes of hepatitis. 107(2):123* ¢ Canker sores, treatment and prevention. (CC) ¢ Infectious mononucleosis, diagnosis and LIVER DISEASES 107(1):255 management. 107(7):175* ¢ Genetic, in adults, early recognition of three MUSCULOSKELETAL DISORDERS * Infectious vaginitis, diagnosis and treatment. most common causes. 107(2):147* ¢ Osteoporosis, prevention, detection, and treat- 107(4):63* * Hepatitis. (PN) 107(2):279 ment. 107(7):37* * Leprosy (Hansen's disease), diagnosis and ¢ Hepatitis B and C, chronic, indications for and MYOCARDIAL INFARCTION: See Cardiovascu- treatment. (PP) 107(5):87 contraindications to antiviral therapy. 107(2):135* lar diseases © Lower respiratory tract, viral pathogens in im- ¢ Hepatitis B, healthcare workers who do not munocompromised host. 107(2):67* respond to vaccine. (CC) 107(3):97 NEOPLASMS * Lyme disease characterized by erythema mi- * Hepatocellular carcinoma, guide to detection, ¢ Adenocarcinoma, risk from columnar-lined grans, diagnosis and treatment. (PD) 107(5):51 treatment, and prevention. 107(5):117* (Barrett's) esophagus. 107(7):59* ¢ Otitis media in children, diagnosis, treatment, ¢ Hepatotoxicity of acetaminophen in users and ¢ Cancer pain, guidelines for safe and effective and prevention. (GL) 107(3):239* nonusers of alcohol. 107(1):189* management. 107(2):267* ¢ Periodontal, risk factor for cardiovascular dis- ¢ Liver function tests, interpreting results to ¢ Colorectal cancer, patient information. (PN) ease. (CC) 107(5):17 narrow diagnosis. 107(2):100* 107(5):185 ¢ Primary HIV, current trends in transmission, e Viral hepatitis, acute and chronic, serologic ¢ Colorectal, importance of education and testing, and treatment. 107(4):114* and molecular testing for accurate identification screening to improve outcomes. 107(5):96* ¢ Respiratory syncytial virus, clinical manifesta- of viral causes. 107(2):123* ¢ Esophageal cancer, role of primary care physi- tions, diagnosis, and treatment. 107(3):46 LONG-TERM CARE cian in diagnosis and treatment. 107(5):109* ¢ Risks in wounds and injuries. 107(4):77 ¢ Physical restraint in nursing homes, reducing ¢ Hepatocellular carcinoma, guide to detection, use. (ED) 107(2):15 continued 200 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED treatment, and prevention. 107(5):117* noninvasive methods of diagnosis and treat- PEDIATRICS ¢ Hereditary cancers, use of genetic screening ment. 107(3):213°* ¢ Acne vulgaris, recent information on topical 107(4):191* ¢ Galactorrhea, three cases demonstrate need therapy, guidelines for setting up treatment e Prostate cancer, diagnosis and treatment for thorough workup. 107(7):165* plans. 107(3):69* 107(1):163 ¢ Pregnancy, risks in patients with Raynaud’s e Adolescent lumbar striae, diagnosis. (PP) ¢ Skin cancer, patient information PN) 107(7) phenomena. (CC) 107(1):47 107(4):237 225 ¢ Premenstrual syndrome, diagnostic criteria e Excessive tearing in infancy and early child- ¢ Thyroid cancer, diagnosis and follow-u treatment to relieve symptoms. 107(5):151* hood, role and treatment of congenital naso- 107(1):119 OCCUPATIONAL DISEASES lacrimal duct obstruction. 107(6):149* NERVE BLOCK ¢ Hepatitis B and healthcare workers, nonre- ¢ Fever without source in young children ¢ Dental, for temporary control of oral, dental sponders to vaccine. (CC) 107(3):97 107(2):259* and facial pain. 107(1):229* OSTEOPOROSIS ¢ HIV disease in children, how it differs from NEUROLOGIC MANIFESTATIONS n, and treatment. 107(7):37* disease in adults. 107(4):163* ¢ Cervical spine complications in patients with OTORHINOLARYNGOLOGIC DISEASES * Otitis media, diagnosis, treatment, and pre- rheumatoid arthritis, recognition and manage- ¢ Otitis media in children, diagnosis, treatment vention. (GL) 107(2):239* ment. 107(1):199 and prevention. (GL) 107(3):239* ¢ Parainfluenza virus in childhood, clinical man- ¢ From leprosy, or Hansen’s disease, diagnosis ifestations, diagnosis, and treatment. 107(3):51 and treatment. (PP) 107(5):87 PAIN » Polio vaccine, changesi n administration. (CC) ¢ In insomnia, diagnosis and treatment. 107(3) e Cancer, guidelines fo r safe and adequate 107(1):33 127 management. 107(3):267* ¢ Screening for genetic disorders, pros and ¢ Myasthenia gravis complicated by respiratory ¢ Endometriosis, guidelines for invasive and cons of testing. 107(6):121* failure, essential steps in patient care. 107(4):211* noninvasive methods of diagnosis and treat- * Sleep disorders in children and teens, practi- ¢ Neuromotor side effects of antipsychotics in ment. 107(3):213* cal approach to diagnosis and treatment the elderly. 107(2):169 ¢ Oral, dental, and facial, temporary control us- 107(3):161* ¢ Pain: See Pain ing dental nerve blocks. 107(1):229* PHYSICIAN-PATIENT RELATIONS ¢ Polio, changes in administration of vaccine PATIENT EDUCATION ¢ Effect of ready access to health information in (CC) 107(1):33 ¢ Colorectal cancer. (PN) 107(5):185 today’s media. (ED) 107(6):15 ¢ Postherpetic neuralgia, identifying patients at e For patients with community-acquired pneu- ¢ Possibilities of e-mail communication. (DD) risk. 107(7):113 monia. (GL) 107(2):253 107(7):31 e Restless legs syndrome in parasomnias ¢ Genetic counseling in primary care, likely PHYSICIANS 107(3):153 questions and their answers. 107(3):59* ¢ Barriers to controlling hypertension and dia- * Stroke: See Stroke ¢ Guidelines for improvi ng sleep hygiene. (PN) betes. 107(3):29 NURSING HOMES 107(3):297 * Role in assessing fitness to drive in the elder- e Evaluation and follow-up care for patients in ¢ Hepatitis. (PN) 107(2):279 ly or in patients with dementia. 107(3):229* nursing homes. 107(2):201* e Herpes infections 107(3):194 PNEUMONIA ¢ Physician’s role in directing long-term care e HIV and AIDS update. (PN) 107(4):263 ¢ Community-acquired, guidelines for outpa- 107(2):217* ¢ Hypothyroidism. (PN) 107(1):263 tient management. (GL) 107(2):246* ¢ Reducing use of physical restraint. (ED) e Increasingly available health information, ef- e Viral, clinical characteristics, therapeutic op- 107(2):15 fect on patient-physician relationships. (ED) tions, and preventive measures. 107(3):41* NUTRITION 107(6):15 ¢ Viral, diagnostic approach. 107(1):67* e Foodborne and waterborne infectious dis- ¢ Making patient information available in a wait- ¢ Viral, in inmunocompromised host. 107(2):67* eases, new and reemerging pathogens, changes ing room kiosk. (DD) 107(4):41 PREGNANCY: See Obstetrics/Gynecology in public health programs to minimize future e Skin cancer. (PN) 107(7):225 PREVENTIVE MEDICINE outbreaks. 107(4):245* e Sleep studies to evaluate excessive daytime e Platelet antiaggregants and anticoagulants for ¢ Role of dietary calcium and vitamin D in treat- sleepiness. 107(3):116 secoridary stroke prevention. 107(6):90 ing osteoporosis. 107(7):44 ¢ Stroke. (PN) 107(6):157 ¢ Primary prevention of stroke through modifi- e Understanding sensitive skin. 107(7):77 cation of risk factors. 107(6):34* OBESITY PATIENTS PROSTATIC DISEASES ¢ Risk factor for coronary artery disease in ¢ Barriers to adequate management of cancer ¢ Cancer, diagnosis and treatment. 107(1):163 women. 107(6):112 pain. 107(3):267 PSYCHIATRIC/PSYCHOSOCIAL DISORDERS OBSTETRICS/GYNECOLOGY ¢ Barriers to controlling hypertension and dia- e Antipsychotic drugs in the elderly, avoiding ¢ Endometriosis, guidelines for invasive and betes. 107(3):29 continued 202 VOL 107 / NO 7 / JUNE 2000 /P OSTGRADUATE MEDICINE and minimizing side effects. 107(2):169* ¢ For gonorrhea and syphilis in women ¢ Lyme disease characterized by erythema ¢ Psychological factors in irritable bowel syn- 195 chronicum migrans, diagnosis and treatment drome. 107(3):205 ¢ For hepatocellular carcinoma. 107(5 (PD) 107(5):51 PUBLIC HEALTH ¢ For HIV infection, methods for identifying pri- ¢ Pruritus, generalized, without primary lesions ¢ Foodborne and waterborne infectious dis- mary infection. 107(4):114 differential diagnosis and treatment. (PD) eases, changes in public health programs to ¢ For hypertension in patients with diabetes 107(2):41 minimize future outbreaks. 107(4):245* 107(4):47 * Toxic epidermal necrolysis, report of case. ¢ Objectives for management of hypertension ¢ For parasomnias, questionnaire. 107(3):146 (PD) 107(4):29 107(2):54 ¢ Genetfoir ccan,cer . 107(4):191* SLEEP DISORDERS PULMONARY DISEASES: See Lung diseases: ¢ Genetic, in patients of reproductive age, pros ¢ Excessive daytime sleepiness, evaluation for Respiratory diseases and cons of testing. 107(6):121* cause and effective treatment. 107(3):108* ¢ Lipid, in prevention of coronary artery dis- ¢ Guidelines for improving sleep hygiene. (PN) RECTAL DISEASES ease. (GL) 107(4):229* 107(3):297 * Colorectal cancer, importance of education ¢ Studies for secondary hypertension. 107(5):68 ¢ In children and teens, practical approach to and screening to improve outcomes. 107(5):96* SEXUALLY TRANSMITTED DISEASES diagnosis and treatment. 107(3):161* RESPIRATORY DISEASES ¢ Chlamydia trachomatis and herpes simplex ¢ Insomnia, types, diagnosis, and treatment ¢ Acute chest syndrome in sickle cell disease, infections in women, diagnosis, treatment, and 107(3):127* evaluation and treatment. 107(1):215* prevention. 107(1):55* e Parasomnias, evaluation and treatment ¢ Community-acquired pneumonia, guidelines ¢ Gonorrhea and syphilis in women, screening 107(3):145* for outpatient management. (GL) 107(2):246* diagnosis, and treatment. 107(2):181* SMOKING ¢ Respiratory failure in myasthenia gravis, es- SKIN DISEASES ¢ Independent risk factor for stroke. 107(6):36 sential steps in patient care. 107(4):211* ¢ Acne vulgaris, recent information on topical ¢ Risk factor for coronary artery disease in * Tuberculosis, adjunctive corticosteroids in therapy, guidelines for setting up treatment women. 107(6):112 management. (CC) 107(4):102 plans. 107(3):69* SOCIAL RESPONSIBILITY e Viral pneumonias, clinical characteristics, ¢ Adolescent lumbar striae, diagnosis. (PP) ¢ Doing the right thing for US healthcare, advo- therapeutic options, and preventive measures 107(4):237 cating for a national system. (ED) 107(5):13 107(3):41* ¢ Alopecia areata, clinical overview. 107(7):81* SODIUM ¢ Viral pneumonias, diagnostic approach ¢ Bullous pemphigoid, diagnosis and treatment ¢ Metabolism, disorder, evaluation and man- 107(1):67* (PP) 107(2):231 agement. 107(5):75* ¢ Viral pneumonias in immunocompromised ¢ Cancer, patient information. (PN) 107(7):225 STROKE host. 107(2):67* * Cicatricial pemphigoid, case with ocular in- ¢ Acute ischemic, role of tPA and antithrombot- RHEUMATIC DISEASES volvement. (PP) 107(3):85 ic agents in management. 107(6):85* ¢ Cervical spine complications in patients with ¢ Cosmetic product allergies, evaluation and ¢ Cerebral infarction and transient ischemic at- rheumatoid arthritis, recognition and manage- treatment. 107(7):70* tacks, diagnostic evaluation essential to benefi- ment. 107(1):199 e Erythema multiforme, recognition and man- cial intervention. 107(6):55* e Raynaud's phenomena, risks of pregnancy agement. 107(1):87* ¢ Ischemic, current approaches to primary and (CC) 107(1):47 ¢ Finger “pebbles,” sign of diabetes. (PD) secondary prevention. 107(6):34* RISK FACTORS 107(3):209 ¢ Patient information. (PN) 107(6):157 ¢ For coronary artery disease in women ¢ Fixed drug eruption, differential diagnosis ¢ Prevention, effectiveness of carotid endar- 107(6):111* (PP) 107(7):191 terectomy. 107(6):97* ¢ For herpes zoster. 107(7):107 ¢ Fungal infections, treatment resulting in drug SURGERY ¢ For osteoporosis. 107(7):38 interactions. (PD) 107(1):41 ¢ Carotid endarterectomy for carotid artery ¢ For stroke, current approach to primary pre- ¢ Herpes simplex virus, recurrent, suppressive stenosis, current recommendations. 107(6):97* vention. 107(6):34 and reactive antiviral regimens. (PD) 107(6):139 ¢ Esophagectomy for esophageal cancer. ¢ For sudden death from hypertrophic car- ¢ Herpes zoster, acute and chronic, identifica- 107(5):112 diomyopathy. 107(7):134 tion and treatment. 107(7):107* * Gynecologic, for endometriosis. 107(3):215 ¢ Hirsutism in women, clinical presentation, SCREENING evaluation, and treatment. 107(7):93* TECHNOLOGY ¢ For colorectal cancer, recommendations to ¢ Leprosy (Hansen’s disease), diagnosis and ¢ Communication, increased bandwidth im- improve outcomes. 107(5):98 treatment. (PP) 107(5):87 proves speed and expands options. (DD) ¢ For esophageal cancer, risk factors. 107(5):110 ¢ Lichen amyloidosis, diagnosis and treatment. 107(2):35 (PP) 107(1):249 204 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED THERAPEUTICS VENEREAL DISEASES: See Sexually transmitted ¢ Recurrent herpes simplex virus infection ¢ Ablative procedures in Barrett's esophagus diseases suppressive and reactive antiviral regimens 107(7):64 VIRAL DISEASES (PD) 107(6):139 ¢ Fluid administration, transfusions, and oxy- ¢ Chronic hepatitis B and C, indications for and ¢ Viral hepatitis, acute and chronic, serologic gen therapy for acute chest syndrome in sickle contraindications to antiviral therapy 107(2):135* and motecular testing for accurate identification cell disease. 107(1):217 e Erythema multiforme, recognition and man- of viral causes. 107(2):123* ¢ Substances used in self-treatment of symp- agement. 107(1):87 toms of PMS. 107(5):158 ¢ Hepatitis. (PN) 107 WOMEN e Wound repair options to ensure desired cos- ¢ Herpes simplex vir ns, characteristics ¢ Chlamydia trachomatis and herpes simplex metic result. 107(4):80 and promising treatment options. 107(3):189* infections in women, diagnosis, treatment, and THYROID DISEASES e Herpes zoster, ac d chronic, identifica- prevention. 107(1):55* e Autoimmune, recognition and treatment tion and treatment. 107 ) ¢ Cosmetic product allergies, problem-oriented 107(1):127* ¢ HIV and AIDS update 107(4):263 approach to sensitive skin. 107(7):70* ¢ Hypothyroidism. (PN) 107(1):263 e HiV-associated metabolic and morphologic ¢ Endometriosis, guidelines for invasive and ¢ Nodules, epidemiology, evaluation, and treat- abnormality syndrome, unwelcome effects of noninvasive methods of diagnosis and treat- ment. 107(1):113* antiretroviral therapy. 107(4):141* ment. 107(3):213* e Palpable thyroid abnormalities, identification ¢ HIV disease in childrer it differs from ¢ Galactorrhea, three cases demonstrate need and treatment. 107(1):100* disease in adults. 107(4 for thorough workup. 107(7):165* ¢ Subclinical, diagnostic approach to mild labo- ¢ HIV infection, designing salvage antiretroviral ¢ Gender-specific statistics and prevention strate- ratory abnormalities and vague or absent symp- regimens. 107(4):149* gies for coronary artery disease. 107(6)}:111* toms. 107(1):143* ¢ HIV infection, ethical and fir ancial imperatives ¢ Gonorrhea and syphilis, screening, diagnosis TRAUMA in HIV care. (ED) 107(4):15 and treatment. 107(2):181* ¢ Jellyfish stings, treatment. (CC) 107(4):27 ¢ HIV infection approach to therapy ¢ Health issues, growing interest in compre- ¢ Laceration, systematic approach to repair 107(4):127* hensive care for women. (ED) 107(1):15 107(4):77* e Infectious mon diagnosis and ¢ Hereditary breast cancer syndromes, use of TUBERCULOSIS manager 107 genetic screening. 107(4):193 ¢ Adjunctive corticosteroids in management ¢ Pneumonia, diagnostic approach. 107(1):67* ¢ Hirsutism, clinical presentation, evaluation (CC) 107(4):102 e Pneumonias, clinical characteristics, therapeu- and treatment. 107(7):93°* tic options, and preventive measures. 107(3):41* ¢ Infectious vaginitis, diagnosis and treatment UROLOGIC DISEASES ¢ Pneumonias in ompromised host 107(4):63* ¢ Common problems in the elderly, diagnosis 107(2):67* ¢ Premenstrual syndrome, diagnostic criteria and management, ways to prevent serious com- ¢ Polio, changes in administration of vaccine treatment with medications, nutritional suppie- plicctions. 107(1):163* (CC) 107(1):33 ments, and behavior modifications. 107(5):151* ¢ Primary HIV infection rrent trends in trans- ¢ Urinary incontinence in elderly women, diag- VACCINATION: See Immunization mission, testing, and treatment. 107(4):114* nosis and management. 107(1):169 VASCULAR DISEASES: See Cardiovascular dis- WOUNDS: See Trauma eases Authors ALBERSTONE CD ATTARIAN HP BALLARD EA Cervical spine complications in rheumatoid Helping patients who say they cannot sleep: Excessive tearing in infancy and early child- arthritis patients: Awareness is the key to avert- Practical ways to evaluate and treat insomnia hood: The roie and treatment of congenita! naso- ing serious consequences. 107(1):199 107(3):127 lacrimal duct obstruction. 107(6):149 ANDERSON EG BAUM NH Doing the right thing for US healthcare: Has the BAKRIS G Seven (plus one) secrets of a successful med- time come for a national system? (ED) 107(5):13 Hypertension in patients with diabetes: Why is ical practice: Details make the difference on the ARGUETA R aggressive treatment essential? 107(2):53 business side. (ED) 107(7):19 When a thyroid abnormality is palpable: What Oral antidiabetic agents safe with renal dis- BEDLACK RS it means and what you shoud do. 107(1):100 ease? (CC) 107(7):66 How to handle myasthenic crisis: Essential See also Elliott WJ; Sowers JR steps in patient care. 107(4):211 continued VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE 205 INDEX TO VOLUME 107 CONTINUED BENZEL EC See Alberstone CD COCO AS FACHER JJ BERGERON BP Infectious vaginitis: An accurate Genetic counseling in primary care: What Could your practice use a waiting room kiosk? essential and attainable. 107(4):63 questions are patients likely to ask, and how How to turn waiting time into learning time. (DD) COHAN GR should they be answered? 107(3):59 107(4):41 HIV-associated metabolic and morphologic FALANGA V See Nowak MA Get in with the e-crowd: E-mail can serve your abnormality syndrome: Welcome therapy may FALL PJ practice if kept in check. (DD) 107(7):31 have unwelcome effects. 107(4):141 Hyponatremia and hypernatremia: A system- Getting your hands on decision-support tools: CONRAD DA atic approach to causes and their correction. Where to find clinical practice guidelines and Why changes in administration of polio vac- 107(5):75 best-practice information. (DD) 107(1):27 cine? (CC) 107(1):33 A stepwise approach to acid-base disorders: Need more power in your communication tech- COOPER CJ Practical patient evaluation for metabolic acido- nology? Increasing bandwidth will improve Reducing the use of physical restraints in nurs- sis and other conditions. 107(3):249 speed and expand options. (DD) 107(2):35 ing homes: Regulatory harassment or good FATOURECHI V Protecting your system from digital demons: medicine? (ED) 107(2):15 Demystifying autoimmune thyroid disease: Software vaccines to help you fight off viruses COX C See Draganov P Which disorders require treatment? 107(1):127 (DD) 107(5):21 CURTIS MA FLEMMER MC BERGFELG WF Genetics in primary care practice: Introducing Evidence-based therapy for type 2 diabetes: Hirsutism in women: Effective therapy that is a new series on practical applications of genetic The best and worst of times. 107(5):27 safe for long-term use. 107(7):93 testing and counseling. (ED) 107(3):15 FLEMMING KD BERTOLINO AP Cerebral infarction and transient ischemic at- Alopecia areata: A clinical overview. 107(7):81 DAAR ES See Yu K tacks: Efficient evaluation is essential to benefi- BIANCHI DW See Wheeler PG DEIMUS FA See Nowak MA cial intervention. 107(6):55 BOWERS DH DELUCA M FOX JR Introduction to a symposium on HIV infection. Hypertrophic cardiomyopathy: Tools for identi- Today’s approach to esophageal cancer: What is 107(4):109 fying risk and alleviating symptoms. 107(7):127 the role of the primary care physician? 107(5):109 BRIGDEN ML DODICK DW FRYE GM Problems in interpreting laboratory tests: What Introduction to symposium on stroke. 107(6):29 Is it premenstrual syndrome? Keys to focused do unexpected results mean? 107(7):145 See also Ingall TJ, 107(6):97 diagnosis, therapies for multiple symptoms BRODELL RT DOTY BJ See Powell SL; Wilson JL 107(5):151 Antifungal drug interactions: Avoidance re- DRAELOS ZD FULKERSON P See Kakaiya R quires more than memorization. (PD) 107(1):41 Treating the patient with multiple cosmetic See also Guerriere-Kovach PM; Hollister DS; product allergies: A problem-oriented approach GARCIA J Nowak MA; Watanakunakorn P to sensitive skin. 107(7):70 Sleep disorders in children and teens: Helping pa- BROWN RD Jr See Flemming KD DRAGANOV P tients and their families get some rest. 107(3):161 Aicohol-acetaminophen syndrome: Even mod- GHARIB H See Castro MR CANAVAN TP erate social drinkers are at risk. 107(1):189 GODSHALL SE Managing endometriosis: Strategies to mini- DURRENCE H See Draganov P Infectious mononucleosis: Complexities of a mize pain and damage. 107(3):213 common syndrome. 107(7):175 CASTRO MR ELEWSKI B See Brodell RT GOPAL DV Thyroid nodules and cancer: When to wait and ELLIOTT WJ Abnormal findings on liver function tests: |n- watch, when to refer. 107(1):113 Hypertension in patients with diabetes: Over- terpreting results to narrow the diagnosis and CHIEN JW coming barriers to effective control. 107(3):29 establish a prognosis. 107(2):100; (correction) Viral pneumonias: Epidemic respiratory viruses. ELSAS LJ Il 107(4):24 107(3):41 Cancer genetics in primary care: When is ge- GORDON SC Viral pneumonias: Infection in the immuno- netic screening an option and when is it the Antiviral therapy for chronic hepatitis B and C: compromised host. 107(2):67 standard of care? 107(4):191 Which patients are likely to benefit from which Viral pneumonias: Multifaceted approach to an EMMERT DH agents? 107(2):135; (correction) 107(4):24 elusive diagnosis. 107(1):67 Sexually transmitted diseases in women: GRENDAHL DC See Hartmann LC CHURCH JA Gonorrhea and syphilis. 107(2):181 GUERRIERE-KOVACH PM HIV disease in children: The many ways it dif- See also Kirchner JT Recurrent herpes simpiex virus infection: Sup- fers from the disease in adults. 107(4):163 EPSTEIN M See Bakris G; Sowers JR pressive, reactive, and preventive antiviral regi- mens. (PD) 107(6):139 206 VOL 107 /N O 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED GUTHRIE T See Yale SH JOHNSON JL LEDBETTER LS Pleural effusions in cardiovascular disease: Large, patchy skin eruptions after a hiking trip: HARDY WD Pearls for correlating the evide nce with the cause Erythema chronicum migrans hallmarks Lyme Designing salvage antiretroviral regimens: 107(4):95 disease. (PD) 107(5):51 Some basic guidelines and use of resistance See also Chien JW LEE JB See Ledbetter LS testing. 107(4):149 LICHT HM HARRIS GD KAKAIYA R Irritable bowel syndrome: Definitive diagnostic Compiling the identifying features of bacterial Evaluation of fitness to drive: The physician's criteria help focus symptomatic treatment endocarditis: Vague clues may point to this dan- role in assessing elderly or demented patients 107(3):203 gerous infection. 107(1):75; (correction) 107(4) 107(3):229 LIPSKY MS See King MS 21 KANE JM See Saltz BL LOESCHE WJ HARTMANN LC KATTAR Periodontal infection a risk factor for cardio- Management of cancer pain: Safe, adequate Taking aim at erythema multiforme: How to vascular disease? (CC) 107(5):17 analgesia to improve quality of life. 107(3):267 spot target lesions and less typical presenta- HEATHCOTE JC See Brigden ML tions. 107(1):87 MADDY R See Elliott WJ HITT RS See Hardy WD KING JC MAHOWALD MW HOLLISTER DS Does Raynaud’s phenomenon increase preg- Introduction to symposium on sleep disorders. Finger ‘pebbles’: A dermatologic sign of dia- nancy risks? (CC) 107(1):47 107(3):107 betes mellitus. (PD) 107(3):209 KING MS What is causing excessive daytime sleepi- HSU S Evaluation of nursing home patients: A system- ness? Evaluation to distinguish sleep depriva- A perplexing case of pruritic plaques. (PP) atic approach can improve care. 107(2):201 tion from sleep disorders. 107(3):108 107(2):231 KIRCHNER JT See also Schenck CH Progressive scarring of the conjunctiva. (PP) Sexually transmitted diseases in women: MARIK P 107(3):85 Chlamydia trachomatis and herpes simplex in- Current recommendations for ‘steroid burst’ See also Ledbetter LS: Wood AC; Winter CA fections. 107(1):55 therapy. (CC) 107(1):227 Women’s health issues: Introducing a new se- See also VaronJ iNGALL TJ ries with an underlying emphasis on compre- MARTIN P See Saab S Carotid endarterectomy: Which patients can hensive care. (ED) 107(1):15 MESCHIA JF benefit? 107(6):97 See also Emmert DH: Godshall SE Management of acute ischemic stroke: What is Preventing ischemic stroke: Current approaches KOCUREK K See Wilson JL the role of tPA and antithrombotic agents? to primary and secondary prevention. 107(6):34 KOWDLEY KV See Morrison ED 107(6):85 INSTITUTE FOR CLINICAL SYSTEMS IM- KUWADA SK MISHRIKI YY PROVEMENT Colorectal cancer 2000: Education and screen- Asymptomatic ‘streaks’ in a healthy young Community-acquired pneumonia: Outpatient ing are essential if outcomes are to improve man. (PP) 107(4):237 treatment of patients 16 years and older. (GL) 107(5):96 Two different lesions, same reason. (PP) 107(2):246 Introduction to symposium on gastrointestinal 107(7):191 Lipid screening in adults: Working to prevent cancers. 107(5):93 MORRISON ED coronary artery disease. (GL) 107(4):229 See also Fox JR Genetic liver disease in adults: Early recognition Otitis media in children: Diagnosis, treatment, of the three most common causes. 107(2):147 and prevention. (GL) 107(3):239 LAMBING CL Treatment of lipid disorders in adults: Strat- Osteoporosis prevention, detection, and treat- NADELMAN CM egies in patients with and without known CAD ment: A mandate for primary care physicians Herpes simplex virus infections: New treatment (GL) 107(5):139 107(7):37 approaches make early diagnosis even more im- LANDOW K portant. 107(3):189 JENSON HB Acute and chronic herpes zoster: An ancient NAGIB N See Yale SH Nonresponders to hepatitis B vaccine. (CC) scourge yields to timely therapy. 107(7):107 NEWCOMER VD See Nadelman CM 107(3):97 Best treatment of jellyfish stings? (CC) 107(4):27 NOWAK MA JOHNSON BA Help for canker sores? (CC) 107(1):255 Generalized pruritus without primary lesions: Topical therapy for acne vulgaris: How do you Introduction to symposium on troublesome Differential diagnosis and approach to treat- choose the best drug for each patient? 107(3):69 skin problems. 107(7):69 ment. (PD) 107(2):41 NUNLEY JR See Johnson BA continued VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE 207 INDEX TO VOLUME 107 CONTINUED PARK JW Hypothyroidism. (PN) 107(1):263 VINIK Al See Flemmer MC Fever without source in children: Recommen- Is it time to address our future? Ethica and fi- VOLCHECK GW dations for outpatient care in those up to 3. riancial imperatives in HIV care. (ED) 107(4):15 in-office diagnosis of exercise-induced asthma. 107(2):259 Patient education by proxy? Roadblocks to (CC) 107(2):48 POWELL SL communication between patients and physi- Dental nerve blocks: Toothache remedies for cians. (ED) 107(6):15 WARNER JG Jr See Tamberella MR III the acute-care setting. 107(1):228 Skin cancer. (PN) 107(7):225 WATANAKUNAKORN P PRIER R Toward better sleep. (PN) 107(3):297 Toxic epidermal necrolysis: A widespread, life- Foodborne and waterborne infectious dis- Understanding stroke. (PN) 107(6):157 threatening blistering reaction. (PD) 107(4):29 eases: Contributing factors and solutions to SILVERMAN SD See Frye GM WHEELER PG new and reemerging pathogens. 107(4):245 SMALLRIDGE RC Genetic screening in patients of reproductive Disclosing subclinical thyroid disease: An ap- age: How do you advise prospective parents RADOSH L See Canavan TP proach to mild laboratory abnormalities and who want to know about specific risks? 107(6): REUBEN A See Draganov P vague or absent symptoms. 107(1):143 121 REZNICEK SB SOLNICK JV See Prier R WHITAKER MD Common urologic problems in the elderly: SOQWERS JR Introduction to symposium on thyroid disease. Prostate cancer, outlet obstruction, and inconti- Hypertension in patients with diabetes: 107(1):95 nence. 107(1):163 Strategies for drug therapy to reduce complica- See also Argueta R RIGLER S See Swagerty DL Jr tions. 107(4):47 WHITMAN-ELIA GF ROBERTSON L See Powell SL See also Bakris G, 107(2):53 Galactorrhea may be clue to serious problems: ROBIN NH See Facher JJ STEIMLE J See Harris GD Patients deserve a thorough workup. 107(7):165 ROBINSON DG See Saltz BL STOLLMAN N WILLIAMS M See Bakris G; Sowers JR ROSEN HR See Gopal DV The columnar-lined (Barrett's) esophagus: Can WILLS L See Garcia J ROSENFELD J progression to cancer be prevented? 107(7):59 WILSON JL Heart disease in women: Gender-specific sta- SWAGERTY DL Jr A systematic approach to laceration repair: tistics and prevention strategies for a population The physician’s role in directing long-term Tricks to ensure the desired cosmetic result. at risk. 107(6):111 care: Understanding the rules is important for 107(4):77 protecting your patients and you practice WINDHAM NO See Whitman-Elia GF SAAB S 107(2):217 WINTER CA Introduction to symposium on liver disease. Ominous sign of a disfiguring disease. (PP) 107(2):95 TAK T See DeLuca M 107(5):87 Tests for acute and chronic viral hepatitis: TAMBERELLA MR III WOERNER MG See Saltz BL Finding your way through the alphabet soup of Non-Q wave myocardial infarction: Assess- WOLFE PR infection and superinfection. 107(2):123 ment and management of a unique and diverse Practical approaches to HIV therapy: Recom- SALTZ BL subset. 107(2):87 mendations for the year 2000. 107(4):127 Side effects of antipsychotic drugs: Avoiding TISOVEC R See Kakaiya R WONG TP See Hsu, 107(3):85 and minimizing their impact in elderly patients. TOTO R See Elliott WJ woop AC 107(2):169 TREPANIER A See Elsas LJ II Pruritic papules on the shins. (PP) 107(1):249 SANDERS DB See Bediack RS TSOUKAS MM See Nowak MA SANDLOW JI YALE SH Shattering the myths about male infertility: ULMER SC Acute chest syndrome in sickle cell disease: Treatment of male factors may be more suc- Hepatocellular carcinoma: A concise guide to Crucial considerations in adolescents and cessful and cost-effective than you think. its status and management. 107(5):117 adults. 107(1):215 107(2):235 YU K SCHENCK CH VANDENBOSCHE M See Coco AS Primary HIV infection: Current trends in trans- Parasomnias: Managing bizarre sleep-related VARON J mission, testing, and treatment. 107(4):114 behavior disorders. 107(3):145 Corticosteroids for tuberculosis? (CC) 107(4):102 SETNESS PA See also Marik P ZAHASKY KM See Hartmann LC The ABCs of hepatitis. (PN) 107(2):279 VIDT DG ZIMMERMAN RS See Ingall TJ, 107(6):97 Colorectal cancer. (PN) 107(5):185 Contributing factors in resistant hypertension: Condoms and safe sex. (PN) 107(4):265 Truly refractory disease is rarely found in a prop- HIV and AIDS update. (PN) 107(4):263 erly conducted workup. 107(5):57 208 VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE

ebook img

Postgraduate Medicine 2000: Vol 107 Index PDF

11 Pages·2000·3.6 MB·English
by  
#periodicals #sim_microfilm #pub_postgraduate-medicine
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Postgraduate Medicine 2000: Vol 107 Index

POSTGRADUATE MEDICINE: JANUARY-JUNE 2000 N DE X T 0 VOLUME Subjects ABDOMEN AIRWAY OBSTRUCTION * Dyslipidemia in patients with type 2 diabetes ¢ Pain in irritable bowel syndrome, diagnostic e Asthma, “steroid burst” therapy, current rec- evidence-based therapy. 107(5):31 criteria, treatment options. 107(3):203* ommendations. (CC) 107(1):227 ¢ Endocarditis, bacterial, risk factors, clinical ACNE ¢ Obstructive sleep apnea, evaluation. 107(3):110 presentation, and treatment. 107(1):75* ¢ Topical therapy, guidelines for setting up ALCOHOL ¢ Hypertension in patients with diabetes, need treatment plans. 107(3):69* ¢ Effect on acetaminophen metabolism. 107(1) for aggressive treatment. 107(2):53* ACQUIRED IMMUNODEFICIENCY SYNDROME: 189 ¢ Hypertension in patients with diabetes, over- See AIDS ALLERGY coming barriers to effective control. 107(3):29* ADOLESCENT MEDICINE: See Pediatrics ¢ Cosmetic product allergies, problem-oriented ¢ Hypertension in patients with diabetes, phar- AGING approach to sensitive skin. 107(7):70* macologic interventions to reduce complica- ¢ Bullous pemphigoid, diagnosis and treatment ¢ Toxic epidermal necrolysis, hypersensitivity tions. 107(4):47* (PP) 107(2):231 reaction to trimethoprim-sulfamethoxazole e Hypertension in patients with type 2 diabetes ¢ Common urologic problems, diagnosis and (PD) 107(4):29 evidence-based therapy. 107(5):27 management, ways to prevent serious compli- ANTIBIOTICS: See Drugs, antibiotic ¢ Hypertension, resistant, careful evaluation to cations. 107(1):163* ASTHMA determine contributing factors. 107(5):57* ¢ Evaluation of nursing home patients, system- * Exercise-induced, in-office diagnosis. (CC) ¢ Hypertrophic cardiomyopathy, tools for identi- atic approach. 107(2):201* 107(2):48 fying risk and alleviating symptoms. 107(7):127* ¢ Fitness to drive, assessing the elderly or pa- ¢ “Steroid burst” therapy, current recommen- ¢ Lipid disorders, treatment strategies in pa- tients with dementia. 107(3):229* dations. (CC) 107(1):227 tients with and without known coronary artery ¢ Infectious mononucleosis in older adults disease. (GL) 107(5):139* 107(7):179 BEHAVIOR DISORDERS ¢ Lipid screening in preventing coronary artery ¢ Laboratory data in the elderly. 107(7):156 ¢ In elderly patients, avoiding and minimizing disease. (GL) 107(4):229* ¢ Long-term care, physician’s role in directing side effects of antipsychotic drugs. 107(2):169* ¢ Non-Q wave myocardial infarction, assess- care. 107(2):217* BIOPSY ment and management. 107(2):87* ¢ Physical restraint in nursing home, reducing ¢ Aspiration, of thyroid nodule. 107(1):115 ¢ Pleural effusions, correlating evidence with use. (ED) 107(2):15 ¢ Liver, assessment of abnormal liver enzyme the cause. 107(4):95* ¢ Side effects of antipsychotic drugs, avoiding levels. 107(2):109 ¢ Risk from periodontal infection. (CC) 107(5):17 and minimizing their impact in the elderly BITES AND STINGS ¢ Stroke, acute ischemic, role of tPA and anti- 107(2):169* ¢ Jellyfish stings, treatment. (CC) 107(4):27 thrombotic agents in management. 107(6):85* AIDS BLOOD GLUCOSE ¢ Stroke, ischemic, current approaches to pri- e Ethical and financial imperatives in HIV care. ¢ Hyperglycemia in patients with type 2 dia- mary and secondary prevention. 107(6):34* (ED) 107(4):15 betes, two recent prospective trials. 107(5):33 ¢ Stroke, patient information. (PN) 107(6):157 ¢ HIV disease in children, how it differs from BREAST DISEASES CATHETERIZATION disease in adults. 107(4):163* ¢ Hereditary breast cancer syndromes, use of ¢ Indwelling, management to reduce risk of ¢ Updated patient information. (PN) 107(4):263 genetic screening. 107(4):193 long-term problems. 107(1):177 CHOLESTEROL CANCER: See Neoplasms ¢ Dyslipidemia in patients with type 2 diabetes CARDIOVASCULAR DISEASES evidence-based therapy. 107(5):31 *Major clinical discussion ¢ Carotid artery stenosis, current recommenda- ¢ Effect of lipid levels on risk of coronary artery CC, Curbside Consults DD, Digital Doc tions on carotid endarterectomy. 107(6):97* disease in women. 107(6):113 ED, Editorial ¢ Cerebral infarction and transient ischemic at- ¢ Lipid disorders, treatment strategies in pa- GL, Clinical Practice Guidelines tacks, diagnostic evaluation essential to benefi- tients with and without known coronary artery PD, Pearls in Dermatology cial intervention. 107(6):55* disease. (GL) 107(5):139* PN, Patient Notes ¢ Coronary artery disease in women, gender- ¢ Lipid screening in prevention of coronary artery PP, Puzzles in Practice specific statistics and prevention strategies. disease. (GL) 107(4):229* 107(6):111* continued VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE 197 INDEX TO VOLUME 107 CONTINUED COLONIC DISEASES: See Gastrointestinal dis- ¢ For identification of genetic liver disease in DRUGS, ANTIFUNGAL eases adults. 107(2):147 ¢ Interaction with other drug therapy when treat- COMPUTERS ¢ Goals of diagnostic evaluation in patients with ing superficial fungal infections. (PD) 107(1):41 * CD-ROM decision-support tools, where to find cerebral infarction or transient ischemic attacks. DRUGS, ANTIHYPERTENSIVE Clinical practice guidelines and best-practice in- 107(6):55* ¢ For resistant hypertension, need for carefully formation. (DD) 107(1):27 ¢ In-office diagnosis of exercise-induced asth- conducted evaluation. 107(5):57 « E-mail in your medical practice. (DD) 107(7):31 ma. (CC) 107(2):48 DRUGS, ANTIPLATELET ¢ Equipping a waiting room kiosk with patient ¢ Laboratory and imaging studies in diagnosis e In prevention of ischemic stroke. 107(6):42, 48 information. (DD) 107(4):41 of bacterial endocarditis. 107(1):81 DRUGS, ANTIPSYCHOTIC ¢ Increased bandwidth improves speed and ex- ¢ Serologic and molecular testing for accurate ¢ Avoiding and minimizing side effects in elder- pands options. (DD) 107(2):35 identification of viral causes of acute and chron- ly patients. 107(2):169* e Virus protection software. (DD) 107(5):21 ic hepatitis. 107(2):123* DRUGS, ANTIVIRAL CORTICOSTEROIDS: See Drugs, corticosteroid DIET: See Nutrition ¢ Antiretroviral therapy during primary HIV in- DRUG THERAPY fection. 107(4):129 DELIVERY OF HEALTHCARE ¢ Antihypertensive therapy for resistant hyper- « Antiretroviral therapy for treatment of HIV in- ¢ Secrets of successful medical practice. (ED) tension, need for carefully conducted evalua- fection and AIDS, associated metabolic and 107(7):23 tion. 107(5):57* morphologic abnormalities. 107(4):141* e US healthcare, is it time for a national sys- For bacterial endocarditis. 107(1):82 ¢ Antiretroviral treatment of HIV disease in chil- tem? (ED) 107(5):13 e For both hypertension and hyperglycemia dren. 107(4):171 DEMENTIA 107(2):61 ¢ For acute herpes zoster. 107(7):114 ¢ Effect on fitness to drive, physician’s role in ¢ For diabetic hypertensive patients, pharmaco- ¢ For chronic hepatitis B and C, indications for assessment. 107(3):229* logic interventions to reduce complications. and contraindications to antiviral therapy. DENTAL DISEASES 107(4):47* 107(2):135* ¢ Oral, dental, and facial pain, temporary con- ¢ For HIV infection, recommendations for 2000. ¢ For treatment of herpes infections. 107(3):194 trol using dental nerve blocks. 107(1):229* 107(4):127 * Salvage antiretroviral regimens, basic guide- * Periodontal infection a risk factor for cardio- ¢ For osteoporosis, current options. 107(7):47 lines for design and use of resistance testing. vascular disease. (CC) 107(5):17 ¢ For treatment of endometriosis, characteris- 107(4):149* DIABETES tics of commonly used medications. 107(3):216 ¢ Suppressive and intermittent therapy for re- ¢ Combined with hypertension, need for ag- ¢ Postinfarction treatment regimens. 107(2):90 current herpes simplex virus infection. (PD) gressive treatment. 107(2):53* ¢ Salvage antiretroviral regimens in HIV medi- 107(6):140 ¢ Complicated by hypertension, pharmacologic cine. 107(4):149* DRUGS, BETA BLOCKERS interventions. 107(4):47* ¢ Tissue plasminogen activator therapy in man- ¢ For non—-Q wave infarction. 107(2):91 ¢ Dermatologic sign, finger “pebbles.” (PD) agement of acute ischemic stroke. 107(6):86 DRUGS, CALCIUM CHANNEL 107(3):209 DRUGS, ACE iNHIBITOR ¢ For non—Q wave infarction. 107(2):91 e Risk factor for coronary artery disease in ¢ In non-Q wave infarction. 107(2):90 DRUGS, CORTICOSTEROID women. 107(6):113 DRUGS, ADVERSE REACTION ¢ Adjunctive, in management of pulmonary and * Safety of oral hyperglycemic drugs in patients ¢ Case of toxic epidermal necrolysis induced by extrapulmonary tuberculosis. (CC) 107(4):102 with renal disease. (CC) 107(7):66 trimethoprim-sulfamethoxazole. (PD) 107(4):29 ¢ Intralesional and topical, for alopecia areata. * Type 2, comprehensive staged management e Fixed drug eruption, differential diagnosis. 107(7):84 to improve quality of patient care. 107(5):27* (PP) 107(7):191 e “Steroid burst” therapy for asthma, current ¢ With hypertension, overcoming barriers to ef- DRUGS, ANTIANDROGEN recommendations. (CC) 107(1):227 fective control. 107(3):29* ¢ In treatment of hirsutism. 107(7):101 DRUGS, NONPRESCRIPTION DIAGNOSTIC IMAGING DRUGS, ANTIBIOTIC ¢ Acetaminophen, hepatotoxicity in users and ¢ Evaluation of thyroid nodule. 107(1):114 ¢ For community-acquired pneumonia. (GL) nonusers of alcohol. 107(1):189* ¢ In thyroid cancer. 107(1):123 107(2):251 DRUGS, NONSTEROIDAL ANTI-INFLAMMATORY ¢ Thyroid-imaging techniques. 107(1):103 ¢ For treatment of Lyme disease. (PD) 107(5):52 (NSAIDs) DIAGNOSTIC TECHNIQUES * Gonococcal resistance to antimicrobial thera- ¢ For management of cancer pain. 107(3):268 ¢ Approach to hyperbilirubinemia and jaundice. py. 107(2):183 DRUGS, OPIOID 107(2):108 DRUGS, ANTIDIABETIC * For management of cancer pain. 107(3):269 ¢ Densitometry techniques to measure bone ¢ Oral hyperglycemic agents, safety in patients DRUGS, RETINOID mass. 107(7):39 with renal disease. (CC) 107(7):66 ¢ Tretinoin for acne. 107(3):75 ¢ For hypertrophic cardiomyopathy. 107(7):129 198 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED DRUGS, THROMBOLYTIC genetic screening. 107(4):198 traindications to antiviral therapy. 107(2):135* * Catheter-directed thrombolysis for ischemic ¢ Colorectal cancer, importance of education ¢ B vaccine, what to do about healthcare work- stroke. 107(6):90 and screening to improve outcomes. 107(5):96* ers who are “nonresponders.” (CC) 107(3):97 ¢ Colorectal cancer, patient information. (PN) Patient information. (PN) 107(2):279 EAR DISEASES 107(5):185 ¢ Viral, acute and chronic, serologic and molec- ¢ Otitis media in children, diagnosis, treatment ¢ Columnar-lined (Barrett’s) esophagus, defin- ular testing for accurate identification of viral and prevention. (GL) 107(3):239* ing the condition, current strategies in preven- causes. 107(2):123* ELDERLY: See Aging tion and management. 107(7):59* HEREDITARY DISEASES ENDOCRINE DISORDERS ¢ Esophageal cancer, role of primary care physi- ¢ Genetic counseling in primary care, likely ¢ Autoimmune thyroid disease, recognition and cian in diagnosis and treatment. 107(5):109* questions and their answers. 107(3):59* treatment. 107(1):127* ¢ From foodborne and waterborne infectious * Genetic liver disease in adults, early recogni- ¢ Diabetes: See Diabetes diseases, new and reemerging pathogens tion of three most common causes. 107(2):147* ¢ Galactorrhea, three cases demonstrate need 107(4):245* ¢ Genetic screening in patients of reproductive for thorough workup. 107(7):165* ° Hepatocellular carcinoma, guide to detection, age, pros and cons of testing. 107(6):121* ¢ Hirsutism in women, clinical presentation, treatment, and prevention. 107(5):117* * Genetic testing and counseling. (ED) 107(3):15 evaluation, and treatment. 107(7):93* ¢ Irritable bowel syndrome, diagnostic criteria, ¢ When to use genetic screening for hereditary ¢ Hypothyroidism. (PN) 107(1):263 treatment options. 107(3):203* cancers. 107(4):191* ¢ Male factors in infertility, diagnosis and treat- GENETIC COUNSELING HORMONES ment. 107(2):235* ¢ Current status and expanding horizons. (ED) ¢ Replacement therapy, effect on coronary artery ¢ Palpable thyroid abnormality, identification 107(3):15 disease risk. 107(6):114 and treatment. 107(1):100* ¢ In primary care, likely questions and their an- HYPERTENSION: See Cardiovascular diseases ¢ Premenstrual syndrome, diagnostic criteria, swers. 107(3):59* treatment to relieve symptoms. 107(5):151* GENETIC DISORDERS: See Hereditary diseases IMMUNIZATION ¢ Subclinical, diagnostic approach to mild labo- GENITAL DISEASES ¢ For influenza virus. 107(3):45 ratory abnormalities and vague or absent symp- ¢ Herpes simplex virus type 2 infections, diag- ¢ Hepatitis B vaccine, what to do about health- toms. 107(1):143* nosis and treatment. 107(3):193 care workers who are “nonresponders.” (CC) ¢ Thyroid nodules, epidemiology, evaluation, ¢ Infectious vaginitis, diagnosis and treatment. 107(3):97 and treatment. 107(1):113* 107(4):63* ¢ Polio vaccine, changes in administration. (CC) ETHICS, MEDICAL ¢ Male infertility, myths about, education and 107(1):33 ¢ Ethical and financial imperatives in HIV care. treatment, when to refer. 107(2):235* IMMUNOLOGIC DISEASES (ED) 107(4):15 GERIATRICS: See Aging ¢ Alopecia areata, clinical overview. 107(7):81* EXERCISE GUIDELINES, CLINICAL PRACTICE ¢ Autoimmune thyroid disease, recognition and ¢ Cause of asthma, in-office diagnosis. (CC) ¢ Community-acquired pneumonia, guidelines treatment. 107(1):127* , 107(2):48 for outpatient management. (GL) 107(2):246* ¢ HIV and AIDS update. (PN) 107(4):263 EYE DISORDERS ¢ In treatment of lipid disorders, strategies in ¢ HIV disease in children, how it differs from ¢ Excessive tearing in infancy and early child- patients with and without known coronary disease in adults. 107(4):163* hood, role and treatment of congenital naso- artery disease. (GL) 107(5):139* ¢ HIV infection, practical approach to therapy. lacrimal duct obstruction. 107(6):149* ¢ Lipid screening in prevention of coronary 107(4):127* ¢ Ocular involvement in cicatricial pemphigoid, artery disease. (GL) 107(4):229* e HiV-associated metabolic and morphologic diagnosis and treatment. (PP) 107(3):85 * Otitis media in children, diagnosis, treatment, abnormality syndrome, unwelcome effects of and prevention. (GL) 107(3):239* antiretroviral therapy. 107(4):141* FAMILY PRACTICE ¢ Where to find clinical practice guidelines and * Primary HIV infection, current trends in trans- ¢ Growing need for and interest in addressing best-practice information, CD-ROM decision- mission, testing, and treatment. 107(4):114* women’s health issues. (ED) 107(1):15 support tools. (DD) 107(1):27 e Raynaud’s phenomena, risks of pregnancy. FEVER (CC) 107(1):47 ¢ Without source in young children, recom- HEART DISEASE: See Cardiovascular diseases INCONTINENCE mendations for outpatient care. 107(2):259* HEMATOLOGIC DISEASES e Urinary, in elderly women, diagnosis and FUNGAL DISEASES ¢ Sickle cell disease, recognition of acute chest management. 107(1):169 ¢ Antifungal drug interactions. (PD) 107(1):41 syndrome in adolescents and adults, evaluation INFANTS and treatment. 107(1):215* ¢ Excessive tearing, role and treatment of congen- GASTROINTESTINAL DISEASES HEPATITIS ital nasolacrimal duct obstruction. 107(6):149* ¢ Colon cancer, hereditary syndromes, use of e B and C, chronic, indications for and con- continued VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE 199 INDEX TO VOLUME 107 CONTINUED * Febrile, without toxic signs and symptoms, rec- INFERTILITY ¢ Physician’s role in directing care, understand- ommendations for outpatient care. 107(2):259 ¢ Male, myths about, education and treatment, ing the rules to protect your patients and your INFECTION when to refer. 107(2):235* practice. 107(2):217* ¢ Bacterial endocarditis, risk factors, clinical INFLUENZA ¢ Systematic approach to evaluation of nursing presentation, and treatment. 107(1):75* ¢ Clinical manifestations, diagnosis, and treat- home patients. 107(2):201* ¢ Chlamydia trachomatis and herpes simplex ment. 107(3):41 LUNG DISEASES infections in women, diagnosis, treatment, and INSOMNIA ¢ Acute chest syndrome in sickle cell disease, prevention. 107(1):55* ¢ Types, diagnosis and treatment. 107(3):127* evaluation and treatment. 107(1):215* * Community-acquired pneumonia, guidelines INTERFERON ¢ Pleural effusions in cardiovascular disease, for outpatient management. (GL) 107(2):246* ¢ Therapies for chronic hepatitis B and C correlating evidence with the cause. 107(4):95* ¢ Foodborne and waterborne infectious dis- 107(2):135 LYME DISEASE eases, contributing factors and solutions to new ¢ Erythema migrans, cutaneous hallmark of dis- and reemerging pathogens. 107(4):245* KIDNEY DISEASES ease, diagnosis and treatment. (PD) 107(5):51 ¢ Fungal, treatment resulting in drug interac- ¢ In patients with diabetes, safety of oral hyper- tions. (PD) 107(1):41 glycemic drugs. (CC) 107(7):66 MEDICAL PRACTICE ¢ Gonorrhea and syphilis in women, screening, ¢ Secrets to success, details make the differ- diagnosis, and treatment. 107(2):181* LABORATORY INVESTIGATION ence. (ED) 107(7):23 ¢ Herpes simplex virus, characteristics and ¢ Antiretroviral-drug and HIV-resistance testing ¢ Waiting room kiosk with patient education re- promising treatment options. 107(3):189* in HIV medicine. 107(4):149* sources. (DD) 107(4):41 * Herpes simplex virus, recurrent, suppressive ¢ Diagnosis of viral pneumonia. 107(1):68 MEN and reactive antiviral regimens. (PD) 107(6):139 ¢ Evaluation of thyroid function. 107(1):104 ¢ Common urologic problems in elderly men, ¢ HIV and AIDS update. (PN) 107(4):263 ¢ In diagnosis of infectious mononucleosis. diagnosis and treatment. 107(1):163 * HIV-associated metabolic and morphologic 107(7):177 e Myths about male infertility, education and abnormality syndrome. 107(4):141* « In evaluation of acid-base disorders. 107(3):250 treatment, when to refer. 107(2):235* e HIV, designing salvage antiretroviral regi- ¢ Liver function tests, interpreting results to METABOLIC DISEASES mens, basic guidelines and use of resistance narrow diagnosis. 107(2):100* ¢ Acid-base disorders, step-by-step approach testing. 107(4):149* ¢ Microalbuminuria in patients with type 2 dia- to diagnosis and treatment. 107(3):249* ¢ HIV disease in children, how it differs from betes. 107(5):38 METABOLISM disease in adults. 107(4):163* ¢ Problems in interpreting laboratory test re- ¢ Sodium and water, disorders, general approach ¢ HIV, ethical and financial imperatives. (ED) sults. 107(7):145* to evaluation and management. 107(5):75* 107(4):15 ¢ Serologic and molecular testing for identifica- MOUTH DISEASES * HIV, practical approach to therapy. 107(4):127* tion of viral causes of hepatitis. 107(2):123* ¢ Canker sores, treatment and prevention. (CC) ¢ Infectious mononucleosis, diagnosis and LIVER DISEASES 107(1):255 management. 107(7):175* ¢ Genetic, in adults, early recognition of three MUSCULOSKELETAL DISORDERS * Infectious vaginitis, diagnosis and treatment. most common causes. 107(2):147* ¢ Osteoporosis, prevention, detection, and treat- 107(4):63* * Hepatitis. (PN) 107(2):279 ment. 107(7):37* * Leprosy (Hansen's disease), diagnosis and ¢ Hepatitis B and C, chronic, indications for and MYOCARDIAL INFARCTION: See Cardiovascu- treatment. (PP) 107(5):87 contraindications to antiviral therapy. 107(2):135* lar diseases © Lower respiratory tract, viral pathogens in im- ¢ Hepatitis B, healthcare workers who do not munocompromised host. 107(2):67* respond to vaccine. (CC) 107(3):97 NEOPLASMS * Lyme disease characterized by erythema mi- * Hepatocellular carcinoma, guide to detection, ¢ Adenocarcinoma, risk from columnar-lined grans, diagnosis and treatment. (PD) 107(5):51 treatment, and prevention. 107(5):117* (Barrett's) esophagus. 107(7):59* ¢ Otitis media in children, diagnosis, treatment, ¢ Hepatotoxicity of acetaminophen in users and ¢ Cancer pain, guidelines for safe and effective and prevention. (GL) 107(3):239* nonusers of alcohol. 107(1):189* management. 107(2):267* ¢ Periodontal, risk factor for cardiovascular dis- ¢ Liver function tests, interpreting results to ¢ Colorectal cancer, patient information. (PN) ease. (CC) 107(5):17 narrow diagnosis. 107(2):100* 107(5):185 ¢ Primary HIV, current trends in transmission, e Viral hepatitis, acute and chronic, serologic ¢ Colorectal, importance of education and testing, and treatment. 107(4):114* and molecular testing for accurate identification screening to improve outcomes. 107(5):96* ¢ Respiratory syncytial virus, clinical manifesta- of viral causes. 107(2):123* ¢ Esophageal cancer, role of primary care physi- tions, diagnosis, and treatment. 107(3):46 LONG-TERM CARE cian in diagnosis and treatment. 107(5):109* ¢ Risks in wounds and injuries. 107(4):77 ¢ Physical restraint in nursing homes, reducing ¢ Hepatocellular carcinoma, guide to detection, use. (ED) 107(2):15 continued 200 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED treatment, and prevention. 107(5):117* noninvasive methods of diagnosis and treat- PEDIATRICS ¢ Hereditary cancers, use of genetic screening ment. 107(3):213°* ¢ Acne vulgaris, recent information on topical 107(4):191* ¢ Galactorrhea, three cases demonstrate need therapy, guidelines for setting up treatment e Prostate cancer, diagnosis and treatment for thorough workup. 107(7):165* plans. 107(3):69* 107(1):163 ¢ Pregnancy, risks in patients with Raynaud’s e Adolescent lumbar striae, diagnosis. (PP) ¢ Skin cancer, patient information PN) 107(7) phenomena. (CC) 107(1):47 107(4):237 225 ¢ Premenstrual syndrome, diagnostic criteria e Excessive tearing in infancy and early child- ¢ Thyroid cancer, diagnosis and follow-u treatment to relieve symptoms. 107(5):151* hood, role and treatment of congenital naso- 107(1):119 OCCUPATIONAL DISEASES lacrimal duct obstruction. 107(6):149* NERVE BLOCK ¢ Hepatitis B and healthcare workers, nonre- ¢ Fever without source in young children ¢ Dental, for temporary control of oral, dental sponders to vaccine. (CC) 107(3):97 107(2):259* and facial pain. 107(1):229* OSTEOPOROSIS ¢ HIV disease in children, how it differs from NEUROLOGIC MANIFESTATIONS n, and treatment. 107(7):37* disease in adults. 107(4):163* ¢ Cervical spine complications in patients with OTORHINOLARYNGOLOGIC DISEASES * Otitis media, diagnosis, treatment, and pre- rheumatoid arthritis, recognition and manage- ¢ Otitis media in children, diagnosis, treatment vention. (GL) 107(2):239* ment. 107(1):199 and prevention. (GL) 107(3):239* ¢ Parainfluenza virus in childhood, clinical man- ¢ From leprosy, or Hansen’s disease, diagnosis ifestations, diagnosis, and treatment. 107(3):51 and treatment. (PP) 107(5):87 PAIN » Polio vaccine, changesi n administration. (CC) ¢ In insomnia, diagnosis and treatment. 107(3) e Cancer, guidelines fo r safe and adequate 107(1):33 127 management. 107(3):267* ¢ Screening for genetic disorders, pros and ¢ Myasthenia gravis complicated by respiratory ¢ Endometriosis, guidelines for invasive and cons of testing. 107(6):121* failure, essential steps in patient care. 107(4):211* noninvasive methods of diagnosis and treat- * Sleep disorders in children and teens, practi- ¢ Neuromotor side effects of antipsychotics in ment. 107(3):213* cal approach to diagnosis and treatment the elderly. 107(2):169 ¢ Oral, dental, and facial, temporary control us- 107(3):161* ¢ Pain: See Pain ing dental nerve blocks. 107(1):229* PHYSICIAN-PATIENT RELATIONS ¢ Polio, changes in administration of vaccine PATIENT EDUCATION ¢ Effect of ready access to health information in (CC) 107(1):33 ¢ Colorectal cancer. (PN) 107(5):185 today’s media. (ED) 107(6):15 ¢ Postherpetic neuralgia, identifying patients at e For patients with community-acquired pneu- ¢ Possibilities of e-mail communication. (DD) risk. 107(7):113 monia. (GL) 107(2):253 107(7):31 e Restless legs syndrome in parasomnias ¢ Genetic counseling in primary care, likely PHYSICIANS 107(3):153 questions and their answers. 107(3):59* ¢ Barriers to controlling hypertension and dia- * Stroke: See Stroke ¢ Guidelines for improvi ng sleep hygiene. (PN) betes. 107(3):29 NURSING HOMES 107(3):297 * Role in assessing fitness to drive in the elder- e Evaluation and follow-up care for patients in ¢ Hepatitis. (PN) 107(2):279 ly or in patients with dementia. 107(3):229* nursing homes. 107(2):201* e Herpes infections 107(3):194 PNEUMONIA ¢ Physician’s role in directing long-term care e HIV and AIDS update. (PN) 107(4):263 ¢ Community-acquired, guidelines for outpa- 107(2):217* ¢ Hypothyroidism. (PN) 107(1):263 tient management. (GL) 107(2):246* ¢ Reducing use of physical restraint. (ED) e Increasingly available health information, ef- e Viral, clinical characteristics, therapeutic op- 107(2):15 fect on patient-physician relationships. (ED) tions, and preventive measures. 107(3):41* NUTRITION 107(6):15 ¢ Viral, diagnostic approach. 107(1):67* e Foodborne and waterborne infectious dis- ¢ Making patient information available in a wait- ¢ Viral, in inmunocompromised host. 107(2):67* eases, new and reemerging pathogens, changes ing room kiosk. (DD) 107(4):41 PREGNANCY: See Obstetrics/Gynecology in public health programs to minimize future e Skin cancer. (PN) 107(7):225 PREVENTIVE MEDICINE outbreaks. 107(4):245* e Sleep studies to evaluate excessive daytime e Platelet antiaggregants and anticoagulants for ¢ Role of dietary calcium and vitamin D in treat- sleepiness. 107(3):116 secoridary stroke prevention. 107(6):90 ing osteoporosis. 107(7):44 ¢ Stroke. (PN) 107(6):157 ¢ Primary prevention of stroke through modifi- e Understanding sensitive skin. 107(7):77 cation of risk factors. 107(6):34* OBESITY PATIENTS PROSTATIC DISEASES ¢ Risk factor for coronary artery disease in ¢ Barriers to adequate management of cancer ¢ Cancer, diagnosis and treatment. 107(1):163 women. 107(6):112 pain. 107(3):267 PSYCHIATRIC/PSYCHOSOCIAL DISORDERS OBSTETRICS/GYNECOLOGY ¢ Barriers to controlling hypertension and dia- e Antipsychotic drugs in the elderly, avoiding ¢ Endometriosis, guidelines for invasive and betes. 107(3):29 continued 202 VOL 107 / NO 7 / JUNE 2000 /P OSTGRADUATE MEDICINE and minimizing side effects. 107(2):169* ¢ For gonorrhea and syphilis in women ¢ Lyme disease characterized by erythema ¢ Psychological factors in irritable bowel syn- 195 chronicum migrans, diagnosis and treatment drome. 107(3):205 ¢ For hepatocellular carcinoma. 107(5 (PD) 107(5):51 PUBLIC HEALTH ¢ For HIV infection, methods for identifying pri- ¢ Pruritus, generalized, without primary lesions ¢ Foodborne and waterborne infectious dis- mary infection. 107(4):114 differential diagnosis and treatment. (PD) eases, changes in public health programs to ¢ For hypertension in patients with diabetes 107(2):41 minimize future outbreaks. 107(4):245* 107(4):47 * Toxic epidermal necrolysis, report of case. ¢ Objectives for management of hypertension ¢ For parasomnias, questionnaire. 107(3):146 (PD) 107(4):29 107(2):54 ¢ Genetfoir ccan,cer . 107(4):191* SLEEP DISORDERS PULMONARY DISEASES: See Lung diseases: ¢ Genetic, in patients of reproductive age, pros ¢ Excessive daytime sleepiness, evaluation for Respiratory diseases and cons of testing. 107(6):121* cause and effective treatment. 107(3):108* ¢ Lipid, in prevention of coronary artery dis- ¢ Guidelines for improving sleep hygiene. (PN) RECTAL DISEASES ease. (GL) 107(4):229* 107(3):297 * Colorectal cancer, importance of education ¢ Studies for secondary hypertension. 107(5):68 ¢ In children and teens, practical approach to and screening to improve outcomes. 107(5):96* SEXUALLY TRANSMITTED DISEASES diagnosis and treatment. 107(3):161* RESPIRATORY DISEASES ¢ Chlamydia trachomatis and herpes simplex ¢ Insomnia, types, diagnosis, and treatment ¢ Acute chest syndrome in sickle cell disease, infections in women, diagnosis, treatment, and 107(3):127* evaluation and treatment. 107(1):215* prevention. 107(1):55* e Parasomnias, evaluation and treatment ¢ Community-acquired pneumonia, guidelines ¢ Gonorrhea and syphilis in women, screening 107(3):145* for outpatient management. (GL) 107(2):246* diagnosis, and treatment. 107(2):181* SMOKING ¢ Respiratory failure in myasthenia gravis, es- SKIN DISEASES ¢ Independent risk factor for stroke. 107(6):36 sential steps in patient care. 107(4):211* ¢ Acne vulgaris, recent information on topical ¢ Risk factor for coronary artery disease in * Tuberculosis, adjunctive corticosteroids in therapy, guidelines for setting up treatment women. 107(6):112 management. (CC) 107(4):102 plans. 107(3):69* SOCIAL RESPONSIBILITY e Viral pneumonias, clinical characteristics, ¢ Adolescent lumbar striae, diagnosis. (PP) ¢ Doing the right thing for US healthcare, advo- therapeutic options, and preventive measures 107(4):237 cating for a national system. (ED) 107(5):13 107(3):41* ¢ Alopecia areata, clinical overview. 107(7):81* SODIUM ¢ Viral pneumonias, diagnostic approach ¢ Bullous pemphigoid, diagnosis and treatment ¢ Metabolism, disorder, evaluation and man- 107(1):67* (PP) 107(2):231 agement. 107(5):75* ¢ Viral pneumonias in immunocompromised ¢ Cancer, patient information. (PN) 107(7):225 STROKE host. 107(2):67* * Cicatricial pemphigoid, case with ocular in- ¢ Acute ischemic, role of tPA and antithrombot- RHEUMATIC DISEASES volvement. (PP) 107(3):85 ic agents in management. 107(6):85* ¢ Cervical spine complications in patients with ¢ Cosmetic product allergies, evaluation and ¢ Cerebral infarction and transient ischemic at- rheumatoid arthritis, recognition and manage- treatment. 107(7):70* tacks, diagnostic evaluation essential to benefi- ment. 107(1):199 e Erythema multiforme, recognition and man- cial intervention. 107(6):55* e Raynaud's phenomena, risks of pregnancy agement. 107(1):87* ¢ Ischemic, current approaches to primary and (CC) 107(1):47 ¢ Finger “pebbles,” sign of diabetes. (PD) secondary prevention. 107(6):34* RISK FACTORS 107(3):209 ¢ Patient information. (PN) 107(6):157 ¢ For coronary artery disease in women ¢ Fixed drug eruption, differential diagnosis ¢ Prevention, effectiveness of carotid endar- 107(6):111* (PP) 107(7):191 terectomy. 107(6):97* ¢ For herpes zoster. 107(7):107 ¢ Fungal infections, treatment resulting in drug SURGERY ¢ For osteoporosis. 107(7):38 interactions. (PD) 107(1):41 ¢ Carotid endarterectomy for carotid artery ¢ For stroke, current approach to primary pre- ¢ Herpes simplex virus, recurrent, suppressive stenosis, current recommendations. 107(6):97* vention. 107(6):34 and reactive antiviral regimens. (PD) 107(6):139 ¢ Esophagectomy for esophageal cancer. ¢ For sudden death from hypertrophic car- ¢ Herpes zoster, acute and chronic, identifica- 107(5):112 diomyopathy. 107(7):134 tion and treatment. 107(7):107* * Gynecologic, for endometriosis. 107(3):215 ¢ Hirsutism in women, clinical presentation, SCREENING evaluation, and treatment. 107(7):93* TECHNOLOGY ¢ For colorectal cancer, recommendations to ¢ Leprosy (Hansen’s disease), diagnosis and ¢ Communication, increased bandwidth im- improve outcomes. 107(5):98 treatment. (PP) 107(5):87 proves speed and expands options. (DD) ¢ For esophageal cancer, risk factors. 107(5):110 ¢ Lichen amyloidosis, diagnosis and treatment. 107(2):35 (PP) 107(1):249 204 VOL 107 / NO 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED THERAPEUTICS VENEREAL DISEASES: See Sexually transmitted ¢ Recurrent herpes simplex virus infection ¢ Ablative procedures in Barrett's esophagus diseases suppressive and reactive antiviral regimens 107(7):64 VIRAL DISEASES (PD) 107(6):139 ¢ Fluid administration, transfusions, and oxy- ¢ Chronic hepatitis B and C, indications for and ¢ Viral hepatitis, acute and chronic, serologic gen therapy for acute chest syndrome in sickle contraindications to antiviral therapy 107(2):135* and motecular testing for accurate identification cell disease. 107(1):217 e Erythema multiforme, recognition and man- of viral causes. 107(2):123* ¢ Substances used in self-treatment of symp- agement. 107(1):87 toms of PMS. 107(5):158 ¢ Hepatitis. (PN) 107 WOMEN e Wound repair options to ensure desired cos- ¢ Herpes simplex vir ns, characteristics ¢ Chlamydia trachomatis and herpes simplex metic result. 107(4):80 and promising treatment options. 107(3):189* infections in women, diagnosis, treatment, and THYROID DISEASES e Herpes zoster, ac d chronic, identifica- prevention. 107(1):55* e Autoimmune, recognition and treatment tion and treatment. 107 ) ¢ Cosmetic product allergies, problem-oriented 107(1):127* ¢ HIV and AIDS update 107(4):263 approach to sensitive skin. 107(7):70* ¢ Hypothyroidism. (PN) 107(1):263 e HiV-associated metabolic and morphologic ¢ Endometriosis, guidelines for invasive and ¢ Nodules, epidemiology, evaluation, and treat- abnormality syndrome, unwelcome effects of noninvasive methods of diagnosis and treat- ment. 107(1):113* antiretroviral therapy. 107(4):141* ment. 107(3):213* e Palpable thyroid abnormalities, identification ¢ HIV disease in childrer it differs from ¢ Galactorrhea, three cases demonstrate need and treatment. 107(1):100* disease in adults. 107(4 for thorough workup. 107(7):165* ¢ Subclinical, diagnostic approach to mild labo- ¢ HIV infection, designing salvage antiretroviral ¢ Gender-specific statistics and prevention strate- ratory abnormalities and vague or absent symp- regimens. 107(4):149* gies for coronary artery disease. 107(6)}:111* toms. 107(1):143* ¢ HIV infection, ethical and fir ancial imperatives ¢ Gonorrhea and syphilis, screening, diagnosis TRAUMA in HIV care. (ED) 107(4):15 and treatment. 107(2):181* ¢ Jellyfish stings, treatment. (CC) 107(4):27 ¢ HIV infection approach to therapy ¢ Health issues, growing interest in compre- ¢ Laceration, systematic approach to repair 107(4):127* hensive care for women. (ED) 107(1):15 107(4):77* e Infectious mon diagnosis and ¢ Hereditary breast cancer syndromes, use of TUBERCULOSIS manager 107 genetic screening. 107(4):193 ¢ Adjunctive corticosteroids in management ¢ Pneumonia, diagnostic approach. 107(1):67* ¢ Hirsutism, clinical presentation, evaluation (CC) 107(4):102 e Pneumonias, clinical characteristics, therapeu- and treatment. 107(7):93°* tic options, and preventive measures. 107(3):41* ¢ Infectious vaginitis, diagnosis and treatment UROLOGIC DISEASES ¢ Pneumonias in ompromised host 107(4):63* ¢ Common problems in the elderly, diagnosis 107(2):67* ¢ Premenstrual syndrome, diagnostic criteria and management, ways to prevent serious com- ¢ Polio, changes in administration of vaccine treatment with medications, nutritional suppie- plicctions. 107(1):163* (CC) 107(1):33 ments, and behavior modifications. 107(5):151* ¢ Primary HIV infection rrent trends in trans- ¢ Urinary incontinence in elderly women, diag- VACCINATION: See Immunization mission, testing, and treatment. 107(4):114* nosis and management. 107(1):169 VASCULAR DISEASES: See Cardiovascular dis- WOUNDS: See Trauma eases Authors ALBERSTONE CD ATTARIAN HP BALLARD EA Cervical spine complications in rheumatoid Helping patients who say they cannot sleep: Excessive tearing in infancy and early child- arthritis patients: Awareness is the key to avert- Practical ways to evaluate and treat insomnia hood: The roie and treatment of congenita! naso- ing serious consequences. 107(1):199 107(3):127 lacrimal duct obstruction. 107(6):149 ANDERSON EG BAUM NH Doing the right thing for US healthcare: Has the BAKRIS G Seven (plus one) secrets of a successful med- time come for a national system? (ED) 107(5):13 Hypertension in patients with diabetes: Why is ical practice: Details make the difference on the ARGUETA R aggressive treatment essential? 107(2):53 business side. (ED) 107(7):19 When a thyroid abnormality is palpable: What Oral antidiabetic agents safe with renal dis- BEDLACK RS it means and what you shoud do. 107(1):100 ease? (CC) 107(7):66 How to handle myasthenic crisis: Essential See also Elliott WJ; Sowers JR steps in patient care. 107(4):211 continued VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE 205 INDEX TO VOLUME 107 CONTINUED BENZEL EC See Alberstone CD COCO AS FACHER JJ BERGERON BP Infectious vaginitis: An accurate Genetic counseling in primary care: What Could your practice use a waiting room kiosk? essential and attainable. 107(4):63 questions are patients likely to ask, and how How to turn waiting time into learning time. (DD) COHAN GR should they be answered? 107(3):59 107(4):41 HIV-associated metabolic and morphologic FALANGA V See Nowak MA Get in with the e-crowd: E-mail can serve your abnormality syndrome: Welcome therapy may FALL PJ practice if kept in check. (DD) 107(7):31 have unwelcome effects. 107(4):141 Hyponatremia and hypernatremia: A system- Getting your hands on decision-support tools: CONRAD DA atic approach to causes and their correction. Where to find clinical practice guidelines and Why changes in administration of polio vac- 107(5):75 best-practice information. (DD) 107(1):27 cine? (CC) 107(1):33 A stepwise approach to acid-base disorders: Need more power in your communication tech- COOPER CJ Practical patient evaluation for metabolic acido- nology? Increasing bandwidth will improve Reducing the use of physical restraints in nurs- sis and other conditions. 107(3):249 speed and expand options. (DD) 107(2):35 ing homes: Regulatory harassment or good FATOURECHI V Protecting your system from digital demons: medicine? (ED) 107(2):15 Demystifying autoimmune thyroid disease: Software vaccines to help you fight off viruses COX C See Draganov P Which disorders require treatment? 107(1):127 (DD) 107(5):21 CURTIS MA FLEMMER MC BERGFELG WF Genetics in primary care practice: Introducing Evidence-based therapy for type 2 diabetes: Hirsutism in women: Effective therapy that is a new series on practical applications of genetic The best and worst of times. 107(5):27 safe for long-term use. 107(7):93 testing and counseling. (ED) 107(3):15 FLEMMING KD BERTOLINO AP Cerebral infarction and transient ischemic at- Alopecia areata: A clinical overview. 107(7):81 DAAR ES See Yu K tacks: Efficient evaluation is essential to benefi- BIANCHI DW See Wheeler PG DEIMUS FA See Nowak MA cial intervention. 107(6):55 BOWERS DH DELUCA M FOX JR Introduction to a symposium on HIV infection. Hypertrophic cardiomyopathy: Tools for identi- Today’s approach to esophageal cancer: What is 107(4):109 fying risk and alleviating symptoms. 107(7):127 the role of the primary care physician? 107(5):109 BRIGDEN ML DODICK DW FRYE GM Problems in interpreting laboratory tests: What Introduction to symposium on stroke. 107(6):29 Is it premenstrual syndrome? Keys to focused do unexpected results mean? 107(7):145 See also Ingall TJ, 107(6):97 diagnosis, therapies for multiple symptoms BRODELL RT DOTY BJ See Powell SL; Wilson JL 107(5):151 Antifungal drug interactions: Avoidance re- DRAELOS ZD FULKERSON P See Kakaiya R quires more than memorization. (PD) 107(1):41 Treating the patient with multiple cosmetic See also Guerriere-Kovach PM; Hollister DS; product allergies: A problem-oriented approach GARCIA J Nowak MA; Watanakunakorn P to sensitive skin. 107(7):70 Sleep disorders in children and teens: Helping pa- BROWN RD Jr See Flemming KD DRAGANOV P tients and their families get some rest. 107(3):161 Aicohol-acetaminophen syndrome: Even mod- GHARIB H See Castro MR CANAVAN TP erate social drinkers are at risk. 107(1):189 GODSHALL SE Managing endometriosis: Strategies to mini- DURRENCE H See Draganov P Infectious mononucleosis: Complexities of a mize pain and damage. 107(3):213 common syndrome. 107(7):175 CASTRO MR ELEWSKI B See Brodell RT GOPAL DV Thyroid nodules and cancer: When to wait and ELLIOTT WJ Abnormal findings on liver function tests: |n- watch, when to refer. 107(1):113 Hypertension in patients with diabetes: Over- terpreting results to narrow the diagnosis and CHIEN JW coming barriers to effective control. 107(3):29 establish a prognosis. 107(2):100; (correction) Viral pneumonias: Epidemic respiratory viruses. ELSAS LJ Il 107(4):24 107(3):41 Cancer genetics in primary care: When is ge- GORDON SC Viral pneumonias: Infection in the immuno- netic screening an option and when is it the Antiviral therapy for chronic hepatitis B and C: compromised host. 107(2):67 standard of care? 107(4):191 Which patients are likely to benefit from which Viral pneumonias: Multifaceted approach to an EMMERT DH agents? 107(2):135; (correction) 107(4):24 elusive diagnosis. 107(1):67 Sexually transmitted diseases in women: GRENDAHL DC See Hartmann LC CHURCH JA Gonorrhea and syphilis. 107(2):181 GUERRIERE-KOVACH PM HIV disease in children: The many ways it dif- See also Kirchner JT Recurrent herpes simpiex virus infection: Sup- fers from the disease in adults. 107(4):163 EPSTEIN M See Bakris G; Sowers JR pressive, reactive, and preventive antiviral regi- mens. (PD) 107(6):139 206 VOL 107 /N O 7 / JUNE 2000 / POSTGRADUATE MEDICINE INDEX TO VOLUME 107 CONTINUED GUTHRIE T See Yale SH JOHNSON JL LEDBETTER LS Pleural effusions in cardiovascular disease: Large, patchy skin eruptions after a hiking trip: HARDY WD Pearls for correlating the evide nce with the cause Erythema chronicum migrans hallmarks Lyme Designing salvage antiretroviral regimens: 107(4):95 disease. (PD) 107(5):51 Some basic guidelines and use of resistance See also Chien JW LEE JB See Ledbetter LS testing. 107(4):149 LICHT HM HARRIS GD KAKAIYA R Irritable bowel syndrome: Definitive diagnostic Compiling the identifying features of bacterial Evaluation of fitness to drive: The physician's criteria help focus symptomatic treatment endocarditis: Vague clues may point to this dan- role in assessing elderly or demented patients 107(3):203 gerous infection. 107(1):75; (correction) 107(4) 107(3):229 LIPSKY MS See King MS 21 KANE JM See Saltz BL LOESCHE WJ HARTMANN LC KATTAR Periodontal infection a risk factor for cardio- Management of cancer pain: Safe, adequate Taking aim at erythema multiforme: How to vascular disease? (CC) 107(5):17 analgesia to improve quality of life. 107(3):267 spot target lesions and less typical presenta- HEATHCOTE JC See Brigden ML tions. 107(1):87 MADDY R See Elliott WJ HITT RS See Hardy WD KING JC MAHOWALD MW HOLLISTER DS Does Raynaud’s phenomenon increase preg- Introduction to symposium on sleep disorders. Finger ‘pebbles’: A dermatologic sign of dia- nancy risks? (CC) 107(1):47 107(3):107 betes mellitus. (PD) 107(3):209 KING MS What is causing excessive daytime sleepi- HSU S Evaluation of nursing home patients: A system- ness? Evaluation to distinguish sleep depriva- A perplexing case of pruritic plaques. (PP) atic approach can improve care. 107(2):201 tion from sleep disorders. 107(3):108 107(2):231 KIRCHNER JT See also Schenck CH Progressive scarring of the conjunctiva. (PP) Sexually transmitted diseases in women: MARIK P 107(3):85 Chlamydia trachomatis and herpes simplex in- Current recommendations for ‘steroid burst’ See also Ledbetter LS: Wood AC; Winter CA fections. 107(1):55 therapy. (CC) 107(1):227 Women’s health issues: Introducing a new se- See also VaronJ iNGALL TJ ries with an underlying emphasis on compre- MARTIN P See Saab S Carotid endarterectomy: Which patients can hensive care. (ED) 107(1):15 MESCHIA JF benefit? 107(6):97 See also Emmert DH: Godshall SE Management of acute ischemic stroke: What is Preventing ischemic stroke: Current approaches KOCUREK K See Wilson JL the role of tPA and antithrombotic agents? to primary and secondary prevention. 107(6):34 KOWDLEY KV See Morrison ED 107(6):85 INSTITUTE FOR CLINICAL SYSTEMS IM- KUWADA SK MISHRIKI YY PROVEMENT Colorectal cancer 2000: Education and screen- Asymptomatic ‘streaks’ in a healthy young Community-acquired pneumonia: Outpatient ing are essential if outcomes are to improve man. (PP) 107(4):237 treatment of patients 16 years and older. (GL) 107(5):96 Two different lesions, same reason. (PP) 107(2):246 Introduction to symposium on gastrointestinal 107(7):191 Lipid screening in adults: Working to prevent cancers. 107(5):93 MORRISON ED coronary artery disease. (GL) 107(4):229 See also Fox JR Genetic liver disease in adults: Early recognition Otitis media in children: Diagnosis, treatment, of the three most common causes. 107(2):147 and prevention. (GL) 107(3):239 LAMBING CL Treatment of lipid disorders in adults: Strat- Osteoporosis prevention, detection, and treat- NADELMAN CM egies in patients with and without known CAD ment: A mandate for primary care physicians Herpes simplex virus infections: New treatment (GL) 107(5):139 107(7):37 approaches make early diagnosis even more im- LANDOW K portant. 107(3):189 JENSON HB Acute and chronic herpes zoster: An ancient NAGIB N See Yale SH Nonresponders to hepatitis B vaccine. (CC) scourge yields to timely therapy. 107(7):107 NEWCOMER VD See Nadelman CM 107(3):97 Best treatment of jellyfish stings? (CC) 107(4):27 NOWAK MA JOHNSON BA Help for canker sores? (CC) 107(1):255 Generalized pruritus without primary lesions: Topical therapy for acne vulgaris: How do you Introduction to symposium on troublesome Differential diagnosis and approach to treat- choose the best drug for each patient? 107(3):69 skin problems. 107(7):69 ment. (PD) 107(2):41 NUNLEY JR See Johnson BA continued VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE 207 INDEX TO VOLUME 107 CONTINUED PARK JW Hypothyroidism. (PN) 107(1):263 VINIK Al See Flemmer MC Fever without source in children: Recommen- Is it time to address our future? Ethica and fi- VOLCHECK GW dations for outpatient care in those up to 3. riancial imperatives in HIV care. (ED) 107(4):15 in-office diagnosis of exercise-induced asthma. 107(2):259 Patient education by proxy? Roadblocks to (CC) 107(2):48 POWELL SL communication between patients and physi- Dental nerve blocks: Toothache remedies for cians. (ED) 107(6):15 WARNER JG Jr See Tamberella MR III the acute-care setting. 107(1):228 Skin cancer. (PN) 107(7):225 WATANAKUNAKORN P PRIER R Toward better sleep. (PN) 107(3):297 Toxic epidermal necrolysis: A widespread, life- Foodborne and waterborne infectious dis- Understanding stroke. (PN) 107(6):157 threatening blistering reaction. (PD) 107(4):29 eases: Contributing factors and solutions to SILVERMAN SD See Frye GM WHEELER PG new and reemerging pathogens. 107(4):245 SMALLRIDGE RC Genetic screening in patients of reproductive Disclosing subclinical thyroid disease: An ap- age: How do you advise prospective parents RADOSH L See Canavan TP proach to mild laboratory abnormalities and who want to know about specific risks? 107(6): REUBEN A See Draganov P vague or absent symptoms. 107(1):143 121 REZNICEK SB SOLNICK JV See Prier R WHITAKER MD Common urologic problems in the elderly: SOQWERS JR Introduction to symposium on thyroid disease. Prostate cancer, outlet obstruction, and inconti- Hypertension in patients with diabetes: 107(1):95 nence. 107(1):163 Strategies for drug therapy to reduce complica- See also Argueta R RIGLER S See Swagerty DL Jr tions. 107(4):47 WHITMAN-ELIA GF ROBERTSON L See Powell SL See also Bakris G, 107(2):53 Galactorrhea may be clue to serious problems: ROBIN NH See Facher JJ STEIMLE J See Harris GD Patients deserve a thorough workup. 107(7):165 ROBINSON DG See Saltz BL STOLLMAN N WILLIAMS M See Bakris G; Sowers JR ROSEN HR See Gopal DV The columnar-lined (Barrett's) esophagus: Can WILLS L See Garcia J ROSENFELD J progression to cancer be prevented? 107(7):59 WILSON JL Heart disease in women: Gender-specific sta- SWAGERTY DL Jr A systematic approach to laceration repair: tistics and prevention strategies for a population The physician’s role in directing long-term Tricks to ensure the desired cosmetic result. at risk. 107(6):111 care: Understanding the rules is important for 107(4):77 protecting your patients and you practice WINDHAM NO See Whitman-Elia GF SAAB S 107(2):217 WINTER CA Introduction to symposium on liver disease. Ominous sign of a disfiguring disease. (PP) 107(2):95 TAK T See DeLuca M 107(5):87 Tests for acute and chronic viral hepatitis: TAMBERELLA MR III WOERNER MG See Saltz BL Finding your way through the alphabet soup of Non-Q wave myocardial infarction: Assess- WOLFE PR infection and superinfection. 107(2):123 ment and management of a unique and diverse Practical approaches to HIV therapy: Recom- SALTZ BL subset. 107(2):87 mendations for the year 2000. 107(4):127 Side effects of antipsychotic drugs: Avoiding TISOVEC R See Kakaiya R WONG TP See Hsu, 107(3):85 and minimizing their impact in elderly patients. TOTO R See Elliott WJ woop AC 107(2):169 TREPANIER A See Elsas LJ II Pruritic papules on the shins. (PP) 107(1):249 SANDERS DB See Bediack RS TSOUKAS MM See Nowak MA SANDLOW JI YALE SH Shattering the myths about male infertility: ULMER SC Acute chest syndrome in sickle cell disease: Treatment of male factors may be more suc- Hepatocellular carcinoma: A concise guide to Crucial considerations in adolescents and cessful and cost-effective than you think. its status and management. 107(5):117 adults. 107(1):215 107(2):235 YU K SCHENCK CH VANDENBOSCHE M See Coco AS Primary HIV infection: Current trends in trans- Parasomnias: Managing bizarre sleep-related VARON J mission, testing, and treatment. 107(4):114 behavior disorders. 107(3):145 Corticosteroids for tuberculosis? (CC) 107(4):102 SETNESS PA See also Marik P ZAHASKY KM See Hartmann LC The ABCs of hepatitis. (PN) 107(2):279 VIDT DG ZIMMERMAN RS See Ingall TJ, 107(6):97 Colorectal cancer. (PN) 107(5):185 Contributing factors in resistant hypertension: Condoms and safe sex. (PN) 107(4):265 Truly refractory disease is rarely found in a prop- HIV and AIDS update. (PN) 107(4):263 erly conducted workup. 107(5):57 208 VOL 107 /N O 7 / JUNE 2000 /P OSTGRADUATE MEDICINE

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users